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To Whom it May Concern 
 
Gentlemen, 
 
I have read Dr. Ana María Molina Ruiz Doctoral Thesis entitled 
“Immunohistochemistry in the diagnosis of cutaneous viral and bacterial  
infections” and I think that this research study on immunohistochemistry is very 
interesting both for dermatologists and pathologists nowadays because 
several of the antibodies reviewed in this paper are relatively new and their 
real applicability on daily routine has not been properly established yet. 
 
IHC continues to be one of the main adjunctive methods to conventionally 
stained sections in histopathology. This is mainly related to the fact that it is a 
relatively simple, fast, and inexpensive method. In this review, the authors 
highlight the main immunohistochemical techniques that have been used 
and continue to evolve in the diagnosis of mucocutaneous viral and 
bacterial infections, and discuss their applicability.  
 
Furthermore, I don’t think such an exhaustive study of the 
immunohistochemistry of cutaneous infections has been published previously, 
and therefore this work will probably be used frequently as an expert consult 
paper, both by dermatologists and dermatopathologists.  
 
 
 
Sincerely yours, 
 
 
Priv.-Doz. Dr. med. Heinz Kutzner 
Dermatopathologische Gemeinschaftspraxis 
Postfach 16 46, 88006 Friedrichshafen 
PD Dr. med. Heinz Kutzner, Dermatologe 
Dr. med. Arno Rütten, Dermatologe 
Prof. Dr. med. Thomas Mentzel, Pathologe 
Dr. med. Markus Hantschke, Dermatologe 
Dr. med. Bruno Paredes, Dermatologe, Pathologe 
Dr. med. Leo Schärer, Dermatologe 
 
Postfach  16 46, 88006 Friedrichshafen 
Siemensstr. 6/1, 88048 Friedrichshafen 
MEDICAL UNIVERSITY OF GRAZ   
 
 
To whom it may concern  
DEPARTMENT OF DERMATOLOGY  
CHAIRMAN: PROF. WERNER ABERER, MD  
 
DERMATOPATHOLOGY -REFERENCE CENTER  
RESEARCH UNIT DERMATOPATHOLOGY  
DIRECTOR: PROF. LORENZO CERRONI, MD  
Graz, 21.05.2014  
I have read with great interest the Doctoral Thesis by Dr. Ana María Molina Ruiz, 
titled “Immunohistochemistry in the diagnosis of cutaneous viral and bacterial 
infections”.  
In my opinion this research study on immunohistochemistry of infectious diseases is 
crucial for both dermatologists and dermatopathologists, particularly because several 
of the antibodies discussed and illustrated in the study are new and little-known in the 
dermatologic and dermatopathologic communities. In addition, as infectious disorders 
are a major health problem, and as a precise diagnosis is a pre-requisite for the correct 
treatment, this study addresses a very important problem and offers novel ways of 
properly managing these patients.  
The use of a continuously increasing number of newly raised and commercially 
available antibodies for immunohistochemistry has tremendously broadened the 
applicability of this technique in routine diagnostic procedures, and this is also 
relevant for the diagnosis of different types of infections. Immunohistochemistry 
represents a sensitive, specific and relatively unexpensive technique that allows a 
precise characterization of viral and bacterial infections in biopsy specimens, which 
may be very difficult or even impossible to diagnose using routine microscopy alone.  
Furthermore, to the best of my knowledge this is the only exhaustive and complete 
study of the immunohistochemistry of cutaneous infections that has been published in 
the medical literature, thus representing a crucial reference and source of relevant 
information for both dermatologists and dermatopathologists.  
Sincerely,  
Histopathologic Registry for Cutaneous 
Lymphomas of the Austrian Society of 
Dermatology & Venereology  
Histopathologic Registry for Cutaneous 
Melanomas of the Austrian Society of 
Dermatology & Venereology  
Lorenzo Cerroni, MD (Director) 
Helmut Kerl, MD (Consultant)  
Steven Kaddu, MD Laila El 
Shabrawi-Caelen, MD Cesare 
Massone, MD Isabella Fried, 
MD  
Molecular pathology  
Thomas Wiesner, MD  
Department of Dermatology Division of 
General Dermatology Medical 
University of Graz Auenbruggerplatz 8 
A-8036 Graz, Austria Phone: +43-316-
385-13235 Fax: +43-316-385-14957 E-
mail: lorenzo.cerroni@medunigraz.at  
 
 
Prof. Dr. Lorenzo Cerroni  
Graz General Hospital 
Auenbruggerplatz A-
8036 Graz  
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Abbreviations  
 
IHC: Immunohistochemistry 
IHQ: Inmunohistoquímica 
PCR: Polymerase chain reaction 
ISH: In situ hybridization 
ELISA: Enzyme-linked immunosorbent 
assay  
HSV-1: Herpes simplex virus-1 
HSV-2: Herpes simplex virus-2 
VZV: Varicella zoster virus 
CMV: Cytomegalovirus 
EBV: Epstein-Barr virus 
HHV-6: Human herpesvirus 6 
HHV-7: Human herpesvirus 7 
HHV-8: Human herpesvirus 8 
LMP-1: Latent membrane protein 1  
EBNA-2: Epstein-Barr nuclear antigen 2  
EBERs: Epstein-Barr-encoded RNAs  
HHV-6A: Human Herepesvirus-6 variant A 
HHV-6B: Human Herepesvirus-6 variant B  
KS: Kaposi´s sarcoma 
KSHV: Kaposi´s sarcoma-associated 
herpesvirus  
LNA-1: Latent nuclear antigen-1  
HIV: Human immunodeficiency virus  
HPV: Human papillomavirus  
EV: Epidermodysplasia verruciformis  
SCC: Squamous intraepithelial lesions  
H-E: Hematoxylin and eosin  
PVB19: Parvovirus B19  
PPGSS: Purpuric “gloves-and-socks” 
syndrome  
VP: Viral protein 
HPyV: Human polyomavirus  
MCPyV: Merkel cell polyomavirus  
TSPyV: Trichodysplasia spinulosa 
polyomavirus 
MCC: Merkel cell carcinoma  
DIPS: Detection of integrated 
polyomavirus sequences 
TS: Trichodysplasia spinulosa  
WHO: World Health Organization 
SLAM: signalling lymphocyte activation 
molecule  
HFMD: Hand-foot-and-mouth disease  
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HTLV-1: Human T-cell lymphotropic virus 
type I  
IL: Interleukin  
ATLL: Adult T-cell leukemia/lymphoma  
HBZ: Basic leucine zipper  
EHF: Ebola hemorrhagic fever  
FFPE: Formalin-fixed and paraffin-
embedded  
GAS: Group A Streptococcus 
CDC: Centers for Disease Control  
IDU: Injecting drug users  
PAS: Periodic acid-Schiff  
MTBC: Mycobacterium tuberculosis 
complex  
TB: Tuberculosis 
LAM: Lipoarabinomannan  
HAART: Highly active antiretroviral 
therapy  
WS: Warthin-Starry 
AARB: Acid alcohol resistant bacilli 
FFM: Focus floating microscopy  
LGV: lymphogranuloma venereum  
MSM: men who have sex with men 
MOMP: major outer membrane protein  
DFA: direct fluorescent antibody  
MALT: mucosa associated lymphoid tissue 
RMSF: Rocky Mountain spotted fever  
SFG: Spotted fever group  
IFA: Immunofluorescent antibody assay  
WD: Whipple disease 
SCC: Squamous cell carcinoma  
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Introduction  
 
 
Immunohistochemistry  
Immunohistochemistry (IHC) is an indispensable tool for the surgical 
pathologist that is constantly evolving and expanding. It has wide applications in 
everyday practice, such as determination of the nature, lineage, or differentiation of 
normal cells or tumors; distinguishing between benign and malignant neoplasms; 
assessment of the likely primary site for tumors of uncertain origin; and demonstration 
of the existence of microorganisms.1 With the availability of highly effective antigen 
retrieval techniques, highly sensitive immunohistochemical detection systems, and a 
wide spectrum of new antibodies and with better understanding of the molecular 
alterations in tumors, IHC is also playing an increasingly important role for 
dermatopathologists.2 New immunohistochemical targets are continually being found, 
contributing to more accurate diagnosis and classification of cutaneous disorders.  
 In selected circumstances, IHC can also complement or even replace molecular 
analysis, by serving as a screening tool to triage samples for the latter analysis. 
Compared with molecular studies, immunohistochemical studies are less expensive 
and less labor-intensive, can be performed in routine diagnostic laboratories, and can 
usually be completed in a much shorter time. Therefore, the use of widespread 
immunohistochemical stains in recent years has given the pathologist in general and 
the dermatopathologist specifically many new weapons in their diagnostic 
armamentarium.3   
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 IHC covers a group of immunostaining techniques in which labeled antibodies 
are used to detect the presence of antigens in cells or tissues. The principle of IHC lies 
in the ability of antibodies to bind specifically to their respective antigens. The 
resulting reaction can only be visualized when the antibody is labeled with a substance 
that absorbs or emits light or produces color.4 The principle of IHC has been known 
since the 1930s, but it was not until 1942 that the first IHC study was reported. Coons 
et al. used fluorescent-labeled antibodies to identify Pneumococcal antigens in 
infected tissue. Since then, improvements have been made in protein conjugation, 
tissue fixation methods, detection labels and microscopy, making IHC a routine and 
essential tool in diagnostic and research laboratories.5 
 Immunofluorescence techniques rely on the use of fluorescein-labeled markers, 
which, when exposed to ultraviolet light, emit visible light of varying wavelengths 
depending on the nature of the compound used. Direct immunofluorescence is used 
widely in the diagnosis of skin diseases, a field in which it has very specific indications. 
In particular it is used to diagnose bullous diseases, vasculitis, and certain types of 
tumors. Although it is more sensitive than immunostaining, immunofluorescence has 
certain disadvantages, including loss of fluorescence over time, the need for a 
specialized light microscope, and poor visualization of morphologic features. 
Furthermore, the resulting reactions need to be photographed each time for 
documentation purposes.6  
 Immunoperoxidase techniques involve the use of enzyme labels that convert a 
colorless substrate into a colored one. The most widely used enzymes are peroxidase 
and alkaline phosphatase, and the most widely used substrates are diaminobenzidine,  
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amino ethylcarbazole, and nitroblue tetrazolium, which, respectively, produce a 
brown, red, and blue color. These markers can be attached, or conjugated, directly to 
the primary antibody, or indirectly using secondary antibodies or substances such as 
biotin and protein A.6 
 
Immunohistochemistry in the Diagnosis of Cutaneous Infections 
 The identification of pathogens is of vital importance for the adequate 
treatment of infections, however significant difficulties continue to exist in the 
diagnosis of many infectious diseases. With an increasing number of skin specimens 
from patients with disorders suspected of being infectious, identification of infectious 
agents has become a time-consuming task in routine dermatopathology, where there 
is growing demand for a simple, fast, cost-effective, and highly sensitive screening tool 
for the detection of microorganisms.  
 Traditionally, microbial identification in infectious diseases has been made 
primarily by using conventional microscopy, tissue cultures and serologic assays. Some 
microorganisms have distinctive morphologic characteristics that allow their 
identification in formalin-fixed tissues using routine and special stains. Nevertheless, in 
several instances it is difficult or even impossible to identify an infectious agent 
specifically by conventional morphologic methods. In addition, the sensitivity of tissue 
cultures is limited, particularly in infections with low pathogen numbers or the inability 
to grow the pathogen in culture. In addition, fresh tissue is not always available for 
culture, and culture alone cannot distinguish colonization from tissue invasion. Also, 
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serologic results can be difficult to interpret in the setting of immunosuppression or 
when only a single sample is available for evaluation.  
 Many histochemical "special" stains and a growing number of specific 
monoclonal antibodies, as well as advanced molecular methods, provide a huge 
armamentarium for the detection of microorganisms.2 The molecular diagnosis of 
infectious disease has been growing considerably over the past decade and has 
emerged as an useful tool in the diagnosis of cutaneous infections that are challenging 
and ambiguous on conventional histopathology, thus improving our diagnostic 
accuracy.1 Nucleic acid amplification techniques, such as polymerase chain reaction 
(PCR), ligase chain reaction, transcription-mediated amplification, and nucleic acid 
sequence-based amplification, provide highly accurate diagnosis of numerous 
bacterial, viral, fungal, and parasitic infections involved in a variety of dermatologic 
diseases. In addition, signal amplification with hybrid capture, branched-DNA assays, 
and in situ hybridization (ISH) have been used to detect numerous viral pathogens with 
high degrees of sensitivity and specificity. New technology that involves the use of 
DNA and protein microarrays has also enabled the detection of a variety of genes and 
gene mutations.7-9   
 IHC has a definite role to play in the diagnosis of cutaneous infections. 
However, applications of IHC in this difficult area require a certain degree of 
sophistication and also considerable experience. Although several antibodies have 
been developed to aid in the immunohistochemical diagnosis of many infectious 
diseases, only a small subset of these antibodies is useful in dermatopathology.10 
Moreover, few studies have reviewed IHC utilization by dermatopathologists in the 
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setting of cutaneous infections by virus and bacteria, especially for the more recently 
developed stains. Therefore in this study we describe the immunohistochemical 
findings in the histopathological diagnosis of cutaneous viral and bacterial infections, 
as well as the potential pitfalls commonly encountered in practice. Emphasis is placed 
on new stains as well as novel uses of existing stains. As always, immunohistochemical 
data has been interpreted in the light of clinical and routine histologic findings. 
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Introducción  
 
Inmunohistoquímica  
 La inmunohistoquímica (IHQ) es una herramienta de trabajo indispensable para 
el patólogo general, y un campo en continuo crecimiento y expansión. Es un arma 
diagnóstica que presenta varios campos de aplicación en la práctica diaria como son: la 
determinación de la naturaleza, estirpe y diferenciación de las células tumorales;  la 
distinción entre neoplasias benignas y malignas; la estimación de la procedencia de 
tumores de origen desconocido; y la demostración de la presencia de microorganismos 
en muestras de tejido1. Con la incorporación de técnicas de recuperación antigénica 
altamente efectivas, sistemas de detección IHQ extremadamente sensibles, un amplio 
espectro de nuevos anticuerpos, y una mejor comprensión de las alteraciones 
moleculares de las lesiones tumorales, la IHQ juega también un papel cada vez más 
importante para los dermatopatólogos2. Cada día se descubren nuevas dianas IHQs 
que contribuyen a un diagnóstico más preciso y mejor clasificación de las 
enfermedades cutánenas.  
 En algunas circunstancias especiales, la IHQ puede también complementar o 
incluso sustituir las técnicas moleculares, y servir como una técnica de "screening" que 
permita seleccionar las muestras que precisarán estudios moleculares posteriores. Al 
comparar la IHQ con las técnicas de diagnóstico molecular, la IHQ resulta una técnica 
más rápida, menos costosa económicamente, requiere menos trabajo de laboratorio, y  
puede realizarse en laboratorios no especializados. Todo ello ha motivado el creciente 
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uso de tinciones IHQs en los últimos años, confiriendo a los patólogos en general y más 
concretamente a los dermatopatólogos nuevas armas diagnósticas que complementen 
a las ya existentes3.  
 La IHQ comprende un grupo de técnicas de inmunotinción que permiten 
demostrar una variedad de antígenos presentes en las células o los tejidos utilizando 
anticuerpos marcados. Estas técnicas se basan en la capacidad de los anticuerpos para 
unirse específicamente a los correspondientes antígenos y la reacción se hace visible 
sólo si el anticuerpo está marcado con una sustancia que absorbe o emite luz o 
produce coloración4. Las bases de la IHQ se conocen desde principios de 1930, pero 
hasta 1942 no se publicó el primer estudio con IHQ. Coons y colaboradores utilizaron 
anticuerpos marcados con fluoresceína para identificar antígenos de Pnemococo en 
muestras de tejido lesional. Desde entonces, se han llevado a cabo múltiples mejoras 
en la conjugación de proteinas, técnicas de fijación de tejidos, idenficación de 
antígenos y microscopía que han permitido situar a la IHQ como una técnica esencial y 
de rutina en laboratorios generales y de investigación en todo el mundo5.  
 En las técnicas de inmunofluorescencia se utilizan como marcadores 
compuestos de fluoresceína que bajo luz ultravioleta emiten luz de longitud de onda 
visible, que depende de la naturaleza del compuesto. La inmunofluorescencia directa 
se utiliza frecuentemente en el diagnóstico de las enfermedades cutáneas en donde 
tiene indicaciones muy precisas, como las enfermedades ampollares, las vasculitis o el 
diagnóstico de determinadas neoplasias. Pese a ser más sensible que la IHQ, la 
inmunofluorescencia presenta algunos inconvenientes, como son la pérdida de la 
fluorescencia con el tiempo, la necesidad de una microscopía con luz especializada y la 
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pobreza del detalle morfológico. Además, para documentar cada caso, es necesario 
fotografiar la reacción6. 
 En las técnicas de inmunoperoxidasa se utilizan como marcadores enzimas 
capaces de hacer cambiar de color un sustrato incoloro. Por ejemplo, las enzimas más 
frecuentemente utilizadas son la peroxidasa y la fosfatasa alcalina y los sustratos más 
comunes son la diaminobenzidina (color marrón), el aminoetilcarbazol (color rojo) y el 
nitroazul de tetrazolio (color azul). Estos marcadores pueden unirse (conjugarse) 
directamente al anticuerpo primario o bien indirectamente mediante otros 
anticuerpos (secundarios) o sustancias como biotina o proteína A6.  
 
Inmunohistoquímica en el Diagnóstico de las Infecciones Cutáneas 
 La correcta identificación de los microorganismos resulta esencial para el 
tratamiento adecuado de las infecciones, sin embargo, hoy en día todavía siguen 
existiendo importantes dificultades en el diágnostico de muchas enfermedades 
infecciosas. El número de muestras cutáneas procedentes de pacientes con sospecha 
de padecer una enfermedad infecciosa es cada vez mayor, y la correcta idenfiticación 
de los organismos implicados en la producción de estas enfermedades se ha 
convertido en una tarea laboriosa en dermatopatología, donde cada vez existe una 
mayor demanda por encontrar una técnica de "screening" que resulte a la vez simple, 
rápida, coste-efectiva y altamente sensible en la detección de microorganismos.  
 Tradicionalmente, la identificación de los microorganismos implicados en las 
infecciones cutáneas se ha realizado mediante microscopía óptica, cultivos de 
muestras cutáneas y estudios serológicos. Algunos microorganismos presentan 
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características morfológicas específicas que permiten su identificación en muestras de 
tejido fijado en parafina mediante el uso de tinciones de rutina o especiales. Sin 
embargo, en múltiples ocasiones, la identificación de estos microorganismos resulta 
muy difícil o incluso imposible con el uso aislado de los métodos morfológicos 
convencionales. Además, la sensibilidad de los cultivos es limitada, especialmente en 
infecciones con escaso número de microorganismos o en casos en los que el patógeno 
responsable no crece en los cultivos habituales. Además, no en todos los casos existen 
muestras de tejido disponibles para cultivo, y los cultivos per se no distinguen si un 
patógneo es un mero colonizante o el agente causal de la enfermedad. Por último, la 
interpretación de los estudios serológicos pueden resultar complicada en el contexto 
de pacientes inmunosuprimidos, o cuando sólo se dispone de una única muestra para 
el análisis. 
 En este sentido, las tinciones histoquímicas "especiales", el amplio número de 
anticuerpos monoclonales y métodos moleculares en constante desarrollo, 
constituyen un importante armamento en la correcta identificación de los 
microorganismos.2 El diagnóstico molecular de las enfermedades infecciosas ha 
experimentado un importante crecimiento en la última década y hoy en día constituye 
una herramienta muy valiosa en el diagnóstico de enfermedades infecciosas cutáneas 
que son difíciles de diagnosticar con el uso aislado de la histopatología convecional.1 
Las técnicas de amplificación de ácidos nucléicos, como la reacción en cadena de la 
polimerasa (PCR), la reacción en cadena de la ligasa, la amplificación mediada por 
transcripción, y la amplificación de ácidos nucleicos basada en la secuencia, pueden 
diagnosticar de forma muy precisa un número importante de enfermedades cutáneas 
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debidas a la infección por virus, bacterias, hongos y parásitos. Además, la amplificación 
de la señal con captura de híbridos, los ensayos de ADN ramificado, y la hibridación in 
situ (HIS) también han sido empleados en la detección de numerosos patógenos virales 
con un alto grado de sensibilidad y especificidad. Por último, las nuevas tecnologías 
que implican el uso de ADN  y microarrays de proteínas han permitido la detección de 
una amplia variedad de genes y mutaciones genéticas.7-9   
 En resumen, la IHQ juega un papel definitivo en el diagnóstico de las 
enfermedades infecciosas cutáneas. Sin embargo, el uso adecuado de la IHQ en este 
campo requiere un grado considerable de experiencia, ya que aunque el número de 
anticuerpos que se han desarrollado para el diagnóstico las enfermedades infecciosas 
es muy extenso, solo algunos de estos anticuerpos son realmente útiles en 
dermatopatología.10 Además, existen pocos estudios que analicen la utilidad de la IHQ 
en el contexto de las infecciones cutáneas por virus y bacterias, especialmente en el 
caso de las tinciones IHQs de reciente desarrollo. Por todo ello, este estudio describe 
los hallazgos inmunohistoquímicos en el diagnóstico histopatológico de las infecciones 
cutáneas por virus y bacterias, con hincapié en las nuevas tinciones IHQs así como en 
los nuevos usos de tinciones IHQs ya existentes. Como siempre, los resultados 
obtenidos han sido interpretados en el contexto de los hallazgos clínicos e 
histopatológicos de cada caso, y teniendo en cuenta las posibles dificultades asociadas 
a la práctica diaria. 
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Research objectives  
 
 
Main Objectives 
 1. The main goal of this study is to describe the immunohistochemical findings 
obtained using specific commercially available antibodies to a wide range of viral and 
bacterial pathogens involved in cutaneous infections. 
 2. Another important objective of this study is to test newer stains or new 
applications of older stains, with the purpose of providing novel information on its 
utilization in cutaneous viral and bacterial infections, and describing the diagnostic 
utility of IHC in positive cases. 
 
Secondary Objectives    
 1. For the cutaneous infections tested in this study, the objective is to describe 
the following immunohistochemical information: 
a) The cutaneous structures where viral and bacterial pathogens are expressed in the 
course of infection. 
 b) The specific cells in which viral and bacterial pathogens are expressed in positive 
cases. 
 c) The pattern of distribution of the viral and bacterial antigens within these cells 
(nuclear or cytoplasmatic). 
 2. For the cutaneous infections not tested in this study (because monoclonal 
antibodies for immunohistochemical detection are not commercially available), the 
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objective is to provide a thorough review of the current scientific literature on the 
topic of immunohistochemical detection of viral and bacterial pathogens in the skin. 
This information is intended to be useful both for Dermatologists and 
Dermatopathologists.  
 
 
Material and Methods
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Material and methods  
 
  
 This is a descriptive study based on the collection file material of the authors 
from 1995 to 2014, which included several hundreds of cutaneous tissue samples from 
patients with a wide range of different viral and bacterial infections with cutaneous 
involvement. The main goal of the study was to immunohistochemically detect specific 
viral and bacterial pathogens infecting the skin, and describe the particular 
immunohistochemical findings of the cases in which a positive detection was achieved. 
 The total number of biopsy samples in our files and the relative frequency of 
each one of them were beyond the areas of interest of the study.  
 
Medline search 
 For each cutaneous viral and bacterial infection, a comprehensive search of the 
previous scientific literature was performed in Medline. Relevant articles, chapters, 
and books published until 1 June 2014, regarding the immunohistochemical detection 
of viral and bacterial pathogens in the course of cutaneous infection were identified. 
The search was conducted using the key term combinations: "immunohistochemistry", 
"cutaneous infections", "viral infections", "bacterial infections", and other relevant 
terms specific for each different infection. Papers written in English or Spanish were 
included. Publications found through this indexed search were reviewed for further 
relevant references. We also included case reports that described the 
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immunohistochemical detection of particular viral or bacterial pathogens in the skin 
and other organs. 
 The search strategy covered three facets:  
 
1) Identify which viral and bacterial pathogens had been immunohistochemically 
detected using specific monoclonal antibodies in human tissues.  
2) Identify which of these monoclonal antibodies for viral and bacterial pathogens had 
been tested in cutaneous tissue samples of patients with infectious diseases.  
3) Identify which of these monoclonal antibodies were commercially available. 
 
Tissue samples  
 Formalin-fixed, paraffin-embedded specimens of infectious disorders were 
selected from the files of the Pathology Department, Fundación Jiménez Díaz, Madrid, 
collected from 1995 to 2014. These files contained clinical data including symptoms 
and biopsy day for each patient. In all cases the diagnosis had been confirmed by 
histochemical stains, clinical data, or additional laboratory investigations. 
Histochemical stains (periodic acid–Schiff, Grocott methenamine silver, mucicarmine, 
Ziehl-Neelsen, Gram) were performed according to established procedures. 
 Representative sections stained with hematoxylin-eosin were evaluated for 
histological features by the authors, and blocks were selected on the basis of suitable 
tissue to perform immunohistochemical studies. In addition, normal tissues (variable 
with each microorganism, but mostly lymphatic nodes and skin) were placed as 
internal controls. 
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 This study was deliberately restricted to diseases in which the detection of 
organisms could be achieved using commercially available antibodies. Not included 
were microorganisms that have shown positive immunohistochemical detection with 
private non-commercially available antibodies described in the scientific literature or 
developed for research purposes at the Centers of Disease Control (CDC) in Atlanta.  
 
Immunohistochemistry  
 Immunohistochemical staining was performed both at the Pathology 
Department of Fundación Jiménez Díaz University Hospital in Madrid and the 
Dermatopathology Laboratory at Friedrichshafen, Germany. For immunohistochemical 
examination, formalin-fixed tissue sections (4-μm thick) were deparaffinized in xylene 
and redehydrated in graded alcohols and distilled water. Automated immunostaining 
was performed on a BioTek Solutions TechMate 500 (Dako, Hamburg, Germany) where 
1-hour incubation with a primary antibody was performed.   
 Immunohistochemical staining was performed using the following 25 
commercially available primary antibodies against biologically relevant proteins of 
different viral and bacterial pathogens: 
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Antibody Against Type/Clone 
Herpes simplex virus-1 (HSV-1) Rabbit polyclonal, DAKO 
Herpes simplex virus-1 (HSV-2) Rabbit polyclonal, DAKO 
Varizella zoster virus (VZV) Monoclonal, mouse C90.2.8, Menarini 
Epstein-Barr virus (EBV) Monoclonal, mouse CS1-4, DAKO 
Cytomegalovirus (CMV) Monoclonal, mouse CCH2 + DDG9, DAKO 
Human herpesvirus 8 (HHV-8) Monoclonal, mouse 13B10, Menarini 
Papillomaviruses (HPV) HPV L1: monoclonal, mouse, Cytoimmune 
diagnostics  
HPV cocktail: monoclonal, mouse BPV-1/1H8+, 
CA Zytomed systems 
Parvovirus B19 (PVB19) Monoclonal, mouse R92F6, Menarini 
Merkel cell polyomavirus (MCPyV) Monoclonal, mouse CM2B4, Santa Cruz 
Biotechnology 
SV40 [Trichodysplasia spinulosa 
polyomavirus (TSPyV)] 
Monoclonal, mouse Pab101, BD Biosciences 
Human T-cell lymphotropic virus 
type I (HTLV-1) 
Monoclonal, mouse 1A3, Biozol 
Measles Polyclonal, rabbit, Acris 
Enterovirus Monoclonal, mouse, DAKO 
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Antibody Against Type/Clone 
Staphylococcus aureus Anti-S. aureus, KPL BacTrace, polyclonal, goat; 
Medac 
Streptococcus pyogenes (group A) Anti-Streptococcus A, polyclonal, rabbit; Biorbyt 
Mycobacterium bovis BCG Anti-M. bovis BCG, polyclonal, rabbit; DAKO 
Mycobacterium tuberculosis Anti-M. tuberculosis, polyclonal, rabbit; Zytomed 
Systems 
Treponema pallidum Anti-T. pallidum, polyclonal, rabbit; Zytomed 
Systems 
Borrelia burgdorferi Anti-Borrelia, polyclonal, rabbit; Biogenesis 
Borrelia species Anti-Borrelia species, KPL BacTrace, polyclonal, 
goat; Medac 
Chlamydia trachomatis Anti-C. trachomatis, monoclonal (BDI815), 
mouse; Acris Antibodies 
Bartonella henselae Anti-B. henselae, monoclonal (H2A10), mouse; 
Zytomed Systems 
Bartonella quintana Anti-B. quintana; Xceltis 
Neisseria meningitidis Anti-N. meningitidis, polyclonal, rabbit; Thermo 
Fisher Scientific 
 
 
  
Results
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Results 
 
 
 
 The results of this study have been published as the following critical review 
articles in the American Journal of Dermatopathology: 
 
1. Molina-Ruiz AM, Santonja C, Rütten A, Cerroni L, Kutzner H, Requena L. 
Immunohistochemistry of viral infections. Part I. Cutaneous viral infections by 
herpesviruses and papillomaviruses. American Journal of Dermatopathology. 
2014 Aug 28. [Epub ahead of print] PubMed PMID: 25171431. 
 
2. Molina-Ruiz AM, Santonja C, Rütten A, Cerroni L, Kutzner H, Requena L. 
Immunohistochemistry of viral infections. Part II. Cutaneous Viral Infections by 
Parvoviruses, Poxviruses, Paramyxoviridae, Picornaviridae, Retroviruses and 
Filoviruses. American Journal of Dermatopathology. 2014 Aug 28. [Epub ahead 
of print] PubMed PMID: 25171430. 
 
3. Molina-Ruiz AM, Cerroni L, Kutzner H, Requena L. Immunohistochemistry in the 
diagnosis of cutaneous bacterial infections. American Journal of 
Dermatopathology. 2014. (In press). 
 
 
 
Chapter 1
Immunohistochemistry in the 
Diagnosis of Cutaneous Viral 
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Immunohistochemistry in the Diagnosis of Cutaneous 
Viral Infections - Part I. Cutaneous Viral Infections by 
Herpesviruses and Papillomaviruses 
 
 
 
  
REVIEW ARTICLE
Immunohistochemistry in the Diagnosis of Cutaneous Viral
Infections—Part I. Cutaneous Viral Infections by
Herpesviruses and Papillomaviruses
Ana M. Molina-Ruiz, MD,* Carlos Santonja, MD,† Arno Rütten, MD,‡ Lorenzo Cerroni, MD,§
Heinz Kutzner, MD,‡ and Luis Requena, MD*
Background: Cutaneous viral infections are of increasing clinical
importance, particularly in patients who are immunocompromised.
Objective: The use of immunohistochemistry (IHC) in the diagnosis
of cutaneous infections provides a rapid morphological diagnosis and
can be applied to conﬁrm the diagnosis of speciﬁc viral infections that
may be difﬁcult to diagnose with certainty using routine microscopy
alone, thus facilitating clinical decisions in patient care.
Methods: Several immunostains for speciﬁc viruses that have been
useful in dermatopathology are reviewed. Emphasis is placed on new
stains and novel uses of existing stains.
Results: This article is an up-to-date overview of the potential uses
and limitations of IHC in the histopathologic diagnosis of cutaneous
viral infections by herpesviruses and papillomaviruses.
Limitations: Whereas speciﬁc monoclonal antibodies effectively
distinguish infections by herpes simplex virus-1, herpes simplex
virus-2, varicella zoster virus, Epstein–Barr virus, and cytomegalo-
virus, IHC does not distinguish between the 120 antigenically dis-
tinct strains of human papillomavirus.
Conclusions: IHC may assist dermatopathologists to appropriately
diagnose viral infections caused by herpesviruses and papillomaviruses.
Key Words: immunohistochemistry, virus, skin, infection, herpes-
viruses, papillomaviruses
(Am J Dermatopathol 2014;0:1–12)
LEARNING OBJECTIVES
Upon completion of this learning activity, participants
should be better able to:
1. Use immunohistochemistry (IHC) to identify viral patho-
gens that are relevant to dermatopathology.
2. Apply these techniques in the diagnosis of cutaneous viral
infections and other related diseases.
INTRODUCTION
Various laboratory techniques can be used to assist in
the speciﬁc diagnosis of a suspected viral disease. These
include light and electron microscopy of a biopsy or smear,
serology, viral culture, and immunomorphological methods.
Although viral isolation in tissue culture remains the para-
mount diagnostic method, the development of monoclonal
antibodies to various viruses, for use with ﬂuorescent,
immunoperoxidase, and enzyme-linked immunosorbent assay
techniques, has made possible the rapid diagnosis of many
viral infections with a high degree of speciﬁcity.1 These
markers cannot replace the routine histologic study; however,
they can help to narrow the differential diagnosis.
Immunohistochemistry (IHC) continues to be one of
the main adjunctive methods to conventionally stained
sections in histopathology. This is mainly related to the fact
that it is a relatively simple, fast, and inexpensive method.2
Because of technical advances, there has been a signiﬁcant
increase in the number of diagnostic immunohistochemical
stains available for pathologists and dermatopathologists in
recent years. The sensitivity and speciﬁcity of certain anti-
bodies, their pattern of staining (nuclear, cytoplasmic, or
membranous), and background artifact must be considered
in their interpretation. In addition, evaluation must be done in
relation to internal control.3 IHC, however, is only a tool to
be used appropriately in the context of clinical and histopath-
ologic correlation; unreasonable use can be misleading and
ﬁnancially cost ineffective.4
In this review, we highlight the main immunohisto-
chemical available techniques that have been used and
continue to evolve in the diagnosis of mucocutaneous viral
infections and discuss their applicability.
IMMUNOHISTOCHEMISTRY
IHC has become an increasingly important histopatho-
logic tool over the past 20 years, and is now a key part of
routine practice of dermatopathologists. IHC begins with
antigen retrieval by pretreating the tissue to unmask antigens
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hidden by ﬁxatives, such as formalin. This step is often done
by microwaving the tissue in citrate buffer or other agents,
such as pepsin, proteases, or trypsin. Primary antibody is then
applied, which binds the antigens of interest. After washing
off the excess primary antibody, a secondary antibody is
added to bind the primary antibody. This is then followed by
the addition of an enzyme complex, such as avidin–biotin–
peroxidase complex, and a chromogen.2
Immunoperoxidase techniques involve the use of enzyme
labels that convert a colorless substrate into a colored one. The
most widely used enzymes are peroxidase and alkaline
phosphatase, and the most widely used substrates are diamino-
benzidine, amino ethylcarbazole, and nitroblue tetrazolium,
which, respectively, produce brown, red, and blue colors. These
markers can be attached, or conjugated, directly to the primary
antibody or indirectly using secondary antibodies or substances,
such as biotin and protein A.5
The use of a continuously increasing number of newly
raised and commercially available antibodies for IHC has
tremendously broadened IHC applicability, this being espe-
cially relevant for the diagnosis of different types of
infections.2,4,6 The use of IHC in the diagnosis of cutaneous
infections has recently been applied to conﬁrm the diagnosis
of speciﬁc viral infections that may be difﬁcult to diagnose
with certainty using routine microscopy alone.2,4,7,8 Table 1
lists the main commercially available antibodies for speciﬁc
viruses that can be useful in dermatopathology.
VIRAL PATHOGENS
Viruses are separated into families on the basis of the
type and form of the nucleic acid genome, of the morpho-
logical features of the virus particle, and of the mode of
replication. There are 4 important families involved in
cutaneous viral diseases: the DNA families of Herpesviridae,
Papillomaviridae, and Poxviridae, and the RNA family
Picornaviridae.1 In addition to these 4 families, exanthemas
can occur in the course of infections with the following fam-
ilies: Adenoviridae, Reoviridae, Togaviridae, Flaviviridae,
Retroviridae, Parvoviridae, Paramyxoviridae, Arenaviridae,
Filoviridae, and Bunyaviridae.2,4,7,8 The 3 major DNA fami-
lies produce lesions that are histologically diagnostic for a dis-
ease or group of diseases, whereas the other viruses,
particularly the RNA viruses, produce lesions that are often
histopathologically nonspeciﬁc, usually showing epidermal
spongiosis and superﬁcial perivascular lymphohistiocytic
inﬁltrate.
MATERIALS AND METHODS
The biopsy specimens were ﬁxed in 10% buffered
formalin and embedded in parafﬁn. For routine histology,
5-mm-thick sections were stained with hematoxylin and eosin.
Immunohistochemical staining was performed both at the
Pathology Department of Fundación Jiménez Díaz University
Hospital in Madrid and the Dermatopathology Laboratory at
Friedrichshafen, Germany. Tissue sections were processed on
a BioTek Solutions TechMate 500 (Dako) where 1-hour incu-
bation with a primary antibody was performed. The
immunohistochemical study of the viral pathogens was per-
formed using the commercially available antibodies described
in Table 1. Several antibodies for speciﬁc viruses described in
the literature were not commercially available at the time of
elaboration of the article; therefore, immunohistochemical
staining for these pathogens could not be tested.
HERPESVIRUSES
More than 80 herpesviruses have been identiﬁed, 8 of
which are known human pathogens. Herpes simplex viruses
TABLE 1. Available Antibodies for Specific Viruses Useful in
Dermatopathology
Antibody Against Type/Clone
HSV-1 Rabbit polyclonal
DAKO
HSV-2 Rabbit polyclonal
DAKO
VZV Monoclonal, mouse
C90.2.8
Menarini
EBV Monoclonal, mouse
CS1-4
DAKO
CMV Monoclonal, mouse
CCH2 + DDG9
DAKO
HHV-6 Monoclonal/OHV-1, OHV-2, p41
HHV-7 Monoclonal/HHV-7 pp85
HHV-8 Monoclonal, mouse
13B10
Menarini
Papillomaviruses (HPV) HPV L1: monoclonal, mouse
Cytoimmune diagnostics
HPV cocktail: monoclonal, mouse
BPV-1/1H8 + CA
Zytomed systems
Parvovirus B19 (PVB19) Monoclonal, mouse
R92F6
Menarini
Merkel cell polyomavirus (MCPyV) Monoclonal, mouse
CM2B4
Santa Cruz Biotechnology
SV40 [trichodysplasia spinulosa
polyomavirus (TSPyV)]
Monoclonal, mouse
Pab101
BD Biosciences
HTLV-1 Monoclonal, mouse
1A3
Biozol
Measles Polyclonal, rabbit
Acris
Enterovirus Monoclonal, mouse
DAKO
ORF Parapoxvirus (ORF) Monoclonal
Ebola virus (EBO) EBO antigen
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(HSVs) belong to the ubiquitous Herpesviridae family of
viruses, which comprises HSV-1, HSV-2, varicella zoster
virus (VZV), cytomegalovirus (CMV), Epstein–Barr virus
(EBV), human herpesviruses (HHV) 6 and 7, and Kaposi
sarcoma (KS)–associated HHV-8.
Herpes Simplex Virus and Varicella Zoster
Virus
Histopathologic ﬁndings of biopsies of fully developed
labial and genital vesicles because of HSV and vesicles
caused by VZV consist of an intraepidermal blister with
varying degrees of epithelial necrosis.9 Two mechanisms are
involved in the formation of intraepidermal vesicles: one is
the ballooning of keratinocytes and the other is the reticular
degeneration of the epidermis.9 The most typical changes of
the infection are evident in the nuclei of epidermal keratino-
cytes, where there is peripheral margination of chromatin
attached to the nuclear membrane. As a consequence, the
keratinocytes show ringed nuclei with a homogeneous
ground-glass appearance combined with ballooning of the
nucleus. The earliest noteworthy abnormality in the cyto-
plasm of these keratinocytes is the presence of vacuolization.9
The histopathologic differential diagnosis of HSV and
VZV infections may be established immunohistochemically.
Immunoperoxidase stains speciﬁc for HSV-1 (Fig. 1), HSV-2
(Fig. 2), and VZV (Fig. 3) are available commercially.10,11 In
all cases, the cells exhibit both nuclear and cytoplasmic stain-
ing, although staining is more intense at the edges of the
infected nuclei, conﬁrming the histopathologic observation
of cells with peripheral margination of chromatin. The inten-
sity of staining varies between cells depending on the type of
infection. In infections by HSV-1 and HSV-2, epidermal
keratinocytes show the strongest staining and only occasion-
ally staining of the superﬁcial portion of the follicular infun-
dibulum can be observed. In early infections because of VZV,
however, the strongest staining is seen in the cells of the outer
root sheath of the hair follicle and in sebocytes of the seba-
ceous gland.12,13 IHC can also demonstrate VZV antigens in
nerves and other dermal structures. Epidermal keratinocytes,
on the contrary, tend to be negative for VZV, at least in the
early stages of infection.13 Based on such immunohistochem-
ical studies and the demonstration of viral antigens in various
cutaneous structures, it has been possible to establish the
sequence of herpes zoster lesion reactivation.9 A histopatho-
logic ﬁnding of folliculosebaceous involvement is character-
istic of incipient erythematous lesions, whereas epidermal
involvement and the formation of vesicles will be found in
fully developed lesions.9,13
Clinicians and pathologists may also wish to use
laboratory tests to establish deﬁnitive diagnosis in the case
of atypical cutaneous manifestations of these viruses. For
example, IHC was able to identify HSV infection in 5
bedridden geriatric patients (type 1 in 3 and type 2 in 2)
with genital ulcers when histology was suggestive of HSV
infection in only 2 of the 5 patients.14,15 Another study
showed that the sensitivity and speciﬁcity of IHC were com-
parable with in situ hybridization (ISH) in diagnosing HSV
infections.16 Similarly, IHC has also been shown to have
higher speciﬁcity and sensitivity than standard microscopic
assessments in diagnosing VZV infection through detection
of VZV ORF63 encoded protein (IE63) and VZV late protein
gE on both smears and formalin-ﬁxed parafﬁn-embedded skin
sections.10 This can be of special signiﬁcance in allowing
early diagnosis of VZV infection in immunocompromised
patients and thus early treatment. VZV infections may also
FIGURE 1. Histopathologic and
immunohistochemical findings in
a cutaneous infection by HSV-1 in the
upper lip. A, Scanning power showing
2 foci of epidermal involvement and
inflammatory infiltrate in the superfi-
cial dermis. B, Higher magnification
demonstrated the characteristic cyto-
pathic effect of herpesvirus infections
in epidermal keratinocytes. C, The
same case immunohistochemically
studied for HSV-1 antibody. D, Posi-
tivity in the nuclei and cytoplasm of
many epidermal keratinocytes. (A and
B, hematoxylin–eosin stain; C and D,
IHC for HSV-1. Original magnifica-
tions: A, ·10; B, ·400; C, ·10;
D, ·400.)
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be differentiated with certainty from HSV infections using
monoclonal antibodies against the VZV envelope glycopro-
tein gp1.17
Epstein–Barr Virus
EBV, or HHV-4, is a DNA g-herpes virus. The DNA
core is surrounded by an icosahedral nucleocapsid of 162
capsomers and the envelope. The EBV genome encodes for
nearly 100 viral proteins. This genome exists in 2 forms:
circular (episomal) and lineal. The episomal form is the one
adopted in latency periods, whereas the lineal form is the one
evidenced during the lytic phase in which EBV replicates.
EBV causes infectious mononucleosis, hairy leukoplakia
in patients with AIDS, Lipschütz ulcer (ulcus vulvae acutum),
FIGURE 2. Histopathologic and
immunohistochemical findings in
a persistent cutaneous infection by
HSV-2 in genital skin of a patient with
AIDS. A, Scanning power showing
irregular epidermal hyperplasia. B,
Higher magnification demonstrated
the characteristic cytopathic effect of
herpesvirus infections in epidermal
keratinocytes. C, The same case im-
munohistochemically studied for
HSV-2 antibody. D, Positivity in the
nuclei and cytoplasm of many epi-
dermal keratinocytes. (A and B,
hematoxylin–eosin stain; C and D,
IHC for HSV-2. Original magnifica-
tions: A, ·10; B, ·400; C, ·10;
D, ·400.)
FIGURE 3. Figure 1. Histopathologic
and immunohistochemical findings in
a necrotic herpes zoster infection
involving the lower back in a patient
with AIDS. A, Scanning power show-
ing epidermal necrosis and inflamma-
tory infiltrate involving the upper and
lower dermis. B, Higher magnification
demonstrated necrotic eccrine coils. C,
The same case immunohistochemi-
cally studied for VZV antibody show-
ing several foci of positivity in the
dermis. D, Positivity in the nuclei and
cytoplasm of many necrotic keratino-
cytes of the eccrine coils. (A and B,
hematoxylin–eosin stain; C and D, IHC
for VZV. Original magnifications:
A, ·10; B, ·400; C, ·10; D, ·400.)
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a variety of benign and malignant lymphoproliferative processes,
and nasopharyngeal lymphoepithelial carcinoma.9,17,18 In immu-
nosuppressed patients, mainly HIV-positive and transplanted
ones, an association between myoid tumors and EBV has
been well established. The spectrum of EBV-associated my-
oid tumors includes leiomyoma, smooth muscle tumor of
uncertain malignant potential, leiomyosarcoma, and myo-
pericytoma. In general, EBV-related myoid tumors show
some clinical peculiarities, such as being multifocal and
appearing in uncommon locations.19–28 EBV-associated leio-
myosarcoma shows a more indolent biological behavior than
classical leiomyosarcomas.24
In dermatology, it is also common to see a maculopap-
ular rash in patients with infectious mononucleosis who have
been treated with ampicillin, because of the presence of
immunoglobulin (Ig) G or IgM antibodies against penicillin,
but not IgE antibodies, as is the case in the hypersensitivity
reaction to penicillin. As mentioned above, histopathologic
ﬁndings in these rashes are nonspeciﬁc.
EBV displays a very high seroprevalence and is charac-
terized by its latent persistence in memory B lymphocytes. The
mere detection of EBV DNA therefore lacks diagnostic
relevance. Switching from latent to replicative infection has
only exceptionally been reported in B lymphocytes, and such
a lytic phenomenon mainly occurs in the epithelia.
There are commercialized antibodies against latent
membrane protein (LMP) 1 detected by conventional IHC
and against Epstein–Barr nuclear antigen (EBNA) 2 detected
by immunoﬂuorescence, but these methods have relatively
low detection sensitivity and accuracy. In contrast, identifying
Epstein-Barr–encoded RNAs (EBERs) by ISH facilitates viral
detection with high sensitivity and speciﬁcity and allows the
visualization of viral RNA in the nucleus of tumor cells. At
the present time, there are commercially available probes that
can be used on parafﬁn-embedded tissue with a permanent
chromogen. Therefore, ISH remains the gold standard for
EBV detection in tissue samples17 (Fig. 4). Western blot, ﬂow
cytometry, and enzyme-linked immunosorbent assay can
potentially detect and measure selected viral proteins for
which antibodies are available. However, the single
most informative protein-based assay is ISH because it per-
mits localization of protein in the context of histopathology,
facilitating assessment of the medical signiﬁcance of the
infection.29 Localization is achievable in parafﬁn-embedded
sections for latent and lytic viral factors, including EBNA1,
EBNA2, LMP1, LMP2, BHRF1, BZLF1, and BRLF1.30
Interpretation of results, deﬁning the spectrum of expressed
genes and their localization to benign- or malignant-appearing
cells, complements EBER ISH for diagnosis of EBV-related
disease.31 Immunostaining with EBV-LMP yields a cytoplas-
mic pattern.12 This marker is useful in the diagnosis of
posttransplant lymphoproliferative disorders, Hodgkin lym-
phoma, and other lymphomas. It is also positive in 25%–
50% of nasopharyngeal carcinomas.12 LMP1 immunostain
(cytoplasmic and membranous localization) has been shown
to be nearly as effective as EBER ISH in identifying EBV in
lymph nodes of patients with infectious mononucleosis.
Likewise, BZLF1 (characterizes lytic viral replication)
immunostains (nuclear staining) have been shown to be
useful in conﬁrming diagnosis of oral hairy leukoplakia in
tongue biopsies of AIDS patients.32
Technical problems can foil interpretation of immuno-
histochemical results. For example, EBNA1 is thought to be
expressed in virtually all latently infected tumors; yet, EBNA1
FIGURE 4. Histopathologic and ISH
findings in a patient with hairy leu-
koplakia and AIDS. A, Irregular epi-
thelial hyperplasia with ballooning
of the keratinocytes of the upper
layers. B, Higher magnification
showing large pale-staining cells in
the upper layers of the epithelium
with irregular wrinkled nuclei. Note
the presence of some intranuclear
inclusion bodies. C, The same case
studied by ISH for EBER. D, Many
nuclei of the keratinocytes of the
upper layers show EBER positivity.
(A and B, hematoxylin–eosin stain;
C and D, ISH for EBER. Original
magnifications: A, ·10; B, ·400;
C, ·10, D, ·400.)
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IHC is not sensitive enough to reliably substitute for EBER
ISH. Furthermore, the 2B4 clone of EBNA1 antibody cross-
reacts with human MAGEA4, potentially causing false-
positive interpretations.33 Problems such as these emphasize
the need to validate laboratory assays before they are used in
clinical investigations.
Cytomegalovirus
CMV belongs to the subgroup of b-herpesviruses. Like
other members of the family Herpesviridae, this virus produces
primary infection, latent infection, and reinfection; however, its
site of latency is not known. CMV infection is especially com-
mon in immune-compromised patients (such as HIV-infected
patients), and the cutaneous manifestations can be quite vari-
able, including ulcers, vesicles, papules, purpuric macules, ver-
rucous lesions, prurigo nodularis–like lesions, and digital
infarcts. In CMV infections, the characteristic observations
are made in the endothelial cells of dermal blood vessels.
The nuclei of these cells have large eosinophilic inclusions
surrounded by a clear halo.34 Less frequently, inclusions sim-
ilar to those found in the nuclei of endothelial cells have also
been described in the nuclei of ﬁbroblasts and macrophages
and also in the nuclei of the epithelial cells of eccrine ducts in
CMV infections.35
CMV skin infection may be difﬁcult to identify by
clinical or histopathologic ﬁndings for various reasons. First,
cutaneous CMV is rare, and the paucity of cases does not lend
itself to microscopists having the opportunity to study a large
number of cases. Second, the clinical manifestations of CMV
infection vary, and there are no speciﬁc clinical ﬁndings that
allow a clinician to suspect the right diagnosis. Third, the
histopathologic ﬁndings of cutaneous CMV are typically
present in scattered cells, and often, only a few cells have
cytopathologic changes.35,36 Therefore, immunohistochemical
analysis may be needed to conﬁrm the diagnosis in the setting
of intense inﬂammation or in cases where only few cells are
infected35 (Fig. 5). IHC allows for rapid diagnosis; its sensi-
tivity is higher than that of light microscopy and is compara-
ble with that of culture and ISH.
Immunostaining with monoclonal anti-CMV antibody
by immunoperoxidase methods gives a nuclear staining pattern
in early-stage infections and a nuclear and cytoplasmic pattern
in late-stage infections.12 The anti-CMV antibody is known to
bind with great avidity to CMV antigen synthesized in both
early and late stages of infection.37
Human Herpesviruses 6 and 7
HHV-6 and HHV-7 are ubiquitous and have been
associated with several cutaneous diseases, including roseola
infantum, infectious mononucleosis, Rosai–Dorfman disease,
pityriasis rosea, lichen planus, hypersensitivity reactions,
graft-versus-host disease, and several other cutaneous mani-
festations, including various malignancies.38 HHV-6 consists
of 2 closely related yet distinct viruses, designated HHV-6
variant A and HHV-6 variant B. HHV-6 variant B is the
etiological agent of the common childhood illness exanthema
subitum, also known as roseola infantum or sixth disease of
childhood. In adults, infection is seen primarily in immuno-
compromised individuals. In immunocompetent patients, the
FIGURE 5. Histopathologic and
immunohistochemical findings in the
border of a perianal ulcer in a HIV-
infected patient. A, Scanning power
showing discrete perivascular in-
filtrates in superficial dermis and
around eccrine units. B, Higher
magnification demonstrated that the
nuclei of some endothelial cells and
perivascular cells contained large
eosinophilic inclusions surrounded
by a clear halo. C, The same case
immunohistochemically studied for
CMV. D, Immunoexpression for CMV
in the cells containing eosinophilic
inclusions in their nuclei. (A and B,
hematoxylin–eosin stain; C and D,
IHC for CMV. Original magnifica-
tions: A, ·10; B, ·400; C, ·10;
D, ·400.)
Molina-Ruiz et al Am J Dermatopathol  Volume 0, Number 0, Month 2014
6 | www.amjdermatopathology.com  2014 Lippincott Williams & Wilkins
Copyright ª Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
infection is usually diagnosed on the basis of its clinical
features. However, the diagnosis in immunocompromised
patients may need additional laboratory methods, including
viral culture, serologic testing, polymerase chain reaction
(PCR) assay, and tissue biopsy.38 The histopathologic ﬁnd-
ings of HHV-6 and HHV-7 cutaneous infections are nonspe-
ciﬁc. Epidermal spongiosis, some degree of vacuolar
degeneration of the basal layer of the epidermis, and a super-
ﬁcial perivascular lymphocytic inﬁltrate may be observed.9
Immunohistochemical detection of HHV-6 and HHV-7
in skin biopsies is not commonly performed in routine clinical
practice. However, several studies have reported positive
results in the course of different clinical settings. Sumiyoshi
et al39 reported positive immunohistochemical staining with
the HHV-6–speciﬁc monoclonal antibodies OHV-1 and
OHV-2, using the avidin–biotin alkaline phosphatase
method, in skin biopsy specimens from patients with pri-
mary HHV-6 infection and erythroderma. They found pos-
itive staining in the lymphocytes infected with HHV-6 in the
skin.39 Yadav et al40 also reported the detection of HHV-6–
associated antigens in formalin-ﬁxed and parafﬁn-embedded
oral tissues from patients with lichen planus, leukoplakia,
and squamous cell carcinoma. They used the mouse
(6A5G3) monoclonal antibody to the HHV-6 gp116/64/
54 KDa component, which is a late protein in the viral
replicative cycle. Furthermore, Broccolo et al41 reported
the immunohistochemical detection of the HHV-7 pp85
and the HHV-6 p41 antigens in skin biopsy specimens of
patients with pityriasis rosea (17% and 67% of patients
analyzed, respectively), suggesting that they might play
an etiological role in this disease. HHV-7 and HHV-6
antigen-positive cells were located mainly in the
perifollicular and papillary dermis, with the exception of
1 patient in whom HHV-7 pp85 was also found in the
epidermal cells.
Human Herpesvirus 8
HHV-8 has been shown to be involved in the develop-
ment of all the epidemiologic variants of KS. This involvement
was demonstrated in 1994 when unique DNA sequences were
isolated from biopsies of KS.42 The virus, initially called
KS-associated herpesvirus, was subsequently renamed
HHV-8. HHV-8 infects the endothelial-derived spindle cells
of KS and CD19+ B cells. This latter event may be etiolog-
ically signiﬁcant in the causation of some cases of multicen-
tric Castleman disease and primary effusion lymphoma.43 It
has also been found in lymphomas and in other lymphopro-
liferative disorders with heterogeneous presentations.44 Its
presence in a number of skin cancers and in lesions of pem-
phigus vulgaris and pemphigus foliaceus has not been satis-
factorily explained, although tropism for lesional skin has
been postulated.45,46
HHV-8 can be detected by PCR in parafﬁn-embedded
tissue, although the viral load seems to be low.47,48 It is much
easier to perform IHC using the commercially available mono-
clonal antibody against HHV-8 that is directed against the
C-terminus of the latent nuclear antigen-1 (LNA-1) encoded
by the ORF-73 gene.49 The presence of HHV-8 in the nuclei of
proliferating cells in KS lesions may be demonstrated in all its
epidemiologic variants and from the earliest phases of the pro-
cess. It is largely conﬁned to the spindle cells in the nodular
phase (Fig. 6), but it is found in the endothelial cells of the slit-
like vessels in the early patch and plaque stages.
FIGURE 6. Histopathologic and
immunohistochemical findings in
a nodular lesion of an elderly male
with classic KS. A, Scanning power
showing a well-circumscribed dermal
nodule. B, Higher magnification
demonstrated short fascicles of spin-
dled or rounded cells (depending on
the cut plane) and small spaces filled
by red cells. C, The same case im-
munohistochemically studied for
HHV-8. D, Immunoexpression for
HHV-8 in most of the nuclei of spin-
dled cells. (A and B, hematoxylin–
eosin stain; C and D, IHC for HHV-8.
Original magnifications: A, ·10;
B, ·400; C, ·10; D ·400.)
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HHV-8 has both a lytic and latent phase of replication.
During the latent phase, viral DNA copies are maintained as
episomes attached to the host chromosome with the help of
LNA-1.50 This explains why LNA-1 immunoreactivity in KS
cells most often appears as stippled nuclear staining. Most
cells in KS lesions and HHV-8–infected cell cultures are
latently infected. In only a small percentage (,5%) of in-
fected cells is lytic HHV-8 replication seen.51 This is clearly
helpful for diagnostic purposes because most KS lesional
cells will accordingly be LNA-1 immunoreactive.
Given the strong association between HHV-8 infection
and KS, positive immunoreactivity for LNA-1 has proved to
be the most useful diagnostic marker to help differentiate
KS from its mimickers, including angiosarcoma, kaposiform
hemangioendothelioma, spindle cell hemangioma, and benign
lymphangioendothelioma, among others.52,53 However,
a minority of conventional angiosarcomas (29%) were found
to be HHV-8 positive,54 whereas no HHV-8 expression could
be observed in radiation-related angiosarcomas.55 LNA-1 IHC
is favored over PCR (for HHV-8) for the evaluation of prob-
lematic vascular proliferations in patients infected with HIV.
LNA-1 is a highly sensitive and speciﬁc immunohistochem-
ical marker for KS in both the general (HIV negative) pop-
ulation and HIV-positive patients.56 HHV-8 immunoreactivity
seems to be unaffected by HIV status, patient age, gender,
tumor recurrence, or the site of the KS lesion.49
Immunostaining KS with LNA-1 for diagnostic pur-
poses is especially useful for the following: (1) Early subtle
patch-stage lesions in which the histopathologic ﬁndings are
not immediately obvious and may be difﬁcult to diagnose on
tissue biopsy. In these cases, inﬂammatory processes are the
main differential diagnosis to be considered, stasis derma-
titis being the most important. Other histopathologic alter-
ations, such as ulceration, lymphedema, and secondary
infections, may obscure the histopathologic characteristic
of KS, rendering viral detection crucial for the diagnosis. (2)
KS lesions that mimic other conditions, like pyogenic
granuloma–like and angiomatous variants of KS. These his-
topathologic variants of KS are characterized by the prolif-
eration of well-formed capillaries organized in lobules and
surrounded by epidermal collarets, with no solid aggregates
of fusiform cells, and they mimic benign vascular prolifer-
ations with a lobular capillary hemangioma pattern.50 (3) KS
presenting in unusual locations. (4) Histopathologic differ-
ential diagnosis with other vascular proliferations mimicking
KS, such as hobnail hemangioma, spindle cell hemangioma,
benign lymphangioendothelioma, and kaposiform heman-
gioendothelioma. The presence of HHV-8, however, seems
not to be fully restricted to KS, as HHV-8 has been detected
(albeit rarely) in some angiosarcomas, hemangiomas, and
dermatoﬁbromas,57 although the meaning of this ﬁnding re-
mains uncertain. Finally, the immunohistochemical demon-
stration of HHV-8 DNA may be a useful adjunct in the
diagnosis of KS by ﬁne-needle aspiration.58
PAPILLOMAVIRUSES
Papillomaviruses are DNA viruses, which replicate in
the nucleus. The only important virus in this group in
dermatopathology is the human papillomavirus (HPV),
which produces various types of warts on different areas
of the skin.59 Several phylogenetic groups may be
distinguished among the more than 150 known HPV types.
Group A HPV types, occurring on genitals and mucous
membranes, and cutaneous group B beta HPV, also associ-
ated with epidermodysplasia verruciformis, are of greatest
signiﬁcance for dermatologists.
The diagnosis of HPV-associated benign and malig-
nant epithelial lesions is predominantly based on clinical
features and conventional histopathology. Two of the most
speciﬁc histopathologic ﬁndings are the presence of koilo-
cytosis, which is not invariable, especially in long-standing
warts, and the so-called koilocytotic atypia, mostly seen at
the granular layer, which consists of nuclear variation in size
and staining pattern, with irregularity of nuclear membrane
and binucleated or multinucleated cells.60 With only few
exceptions (HPV types 4 and 63 with ﬁlamentous inclusion
bodies61 and HPV type 60 with eosinophilic intracytoplas-
mic large granules62), histology does not grant exact speci-
ﬁcation of the HPV type involved.9 Papillomavirus antigen
can be detected by immunoperoxidase methods.63 Immuno-
histochemical detection of the HPV L1 capsid antigen
(Fig. 7) is indicative of replicative HPV infections, but this
method does not facilitate identiﬁcation of the virus type
involved, either. HPV antigens are detected in 64% of acan-
thopapillomas with koilocytes, but not in any lesion without
histologic evidence for koilocytes, thus indicating that IHC
is only of limited value.64
The use of new techniques, such as DNA hybridization,
has allowed the separation of more than 120 antigenically
distinct strains of HPV.65,66 Further genotypes have been
identiﬁed, but not fully characterized. PCR is now used rou-
tinely for the typing of HPV.67 In recent years, attempts have
been made to relate speciﬁc antigenic strains of HPV to par-
ticular clinicopathologic groups of verrucae.68,69
In the ﬁeld of cervical cancer, the identiﬁcation of
HPV-related precancer that is likely to progress to an
invasive carcinoma is very important. Although cervical
cancer screening relies on cervical cytology and high-risk
HPV detection, the histologic diagnosis, and speciﬁcally
lesion grade, is the main parameter that drives clinical
management of screen-positive women. Morphologically
diagnosed squamous intraepithelial lesions regress sponta-
neously in more than half of the cases, but identifying those
likely to persist and progress is not currently possible based
on morphology. It has been suggested that patterns of viral
protein expression may be used to differentiate between self-
limited productive viral infection and a true precancer.70
Some studies have evaluated the immunohistochemical
expression of HPV capsid proteins L1 and L2 in squamous
intraepithelial lesions as a predictive tool for progression.71
Lack of major capsid protein L1 expression has been sug-
gested as a feature in progressive lesions, whereas expres-
sion of the minor capsid protein L2 has not been extensively
evaluated.
Recently, Wititsuwannakul et al72 have evaluated the
sensitivity and speciﬁcity of a commercially available anti-
HPV antibody (BPV-1/1H8 + CAMVIR, ab 2417, Abcam),
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which detects HPV types 1, 6, 11, 16, 18, and 31 in formalin-
ﬁxed parafﬁn-embedded tissue, in 25 lesions (both HPV
induced and non-HPV induced) mostly from the genital region,
compared with ISH and hematoxylin and eosin staining. They
found a sensitivity and speciﬁcity for this anti-HPV antibody of
90.9% and 85.7%, respectively, compared with ISH. IHC, like
ISH, was generally positive in cases showing koilocytes/koilo-
cytotic atypia (86%). However, IHC also detected productive
infection with HPV in 23% (3 of 13) of cases without koilo-
cytes/koilocytotic atypia. Positive immunostaining is mostly
seen in corneocytes, the nuclei of the keratinocytes of the
granular layer, and upper layers of the epidermis (Fig. 8). A
FIGURE 7. Histopathologic and
immunohistochemical findings in
a genital wart from an otherwise
healthy young adult male. A, Scanning
power showing a regular acanthosis of
the epithelium. B, Higher magnifica-
tion showed prominent koilocytosis in
the upper layers of the epithelium. C,
The same case immunohistochemi-
cally studied for HPV L1 capsid anti-
gen. D, Immunoexpression for HPV L1
is seen in many nuclei of the kerati-
nocytes of the upper layers. (A and B,
hematoxylin–eosin stain; C and D, IHC
for HPV L1. Original magnifications:
A, ·10; B, ·400; C, ·10; D, ·400.)
FIGURE 8. Histopathologic and
immunohistochemical findings in
a genital wart from a young adult
woman with history of persistent
condyloma acuminatum involving
the vulva. A, Scanning power of
a shave biopsy showed a thick
compact orthokeratotic horny layer.
B, Higher magnification showed
some koilocytes in the upper layers
of the horny layer. C, The same
case immunohistochemically studied
with CAMVIR antibody. D, Im-
munoexpression for HPV in many
nuclei of the corneocytes of the
upper layers with CAMVIR antibody.
(A and B, hematoxylin–eosin stain; C
and D, IHC for CAMVIR antibody.
Original magnifications: A, ·10;
B, ·400; C, ·10; D, ·400.)
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major disadvantage of IHC, compared with ISH and PCR, is its
inability to type HPV. But IHC shows considerable advantages
over ISH and PCR, such as the low cost, rapid turnaround time,
and the ability to visualize productive HPV infection in tissue
sections.72 Because results of IHC for HPV with this antibody
correlate with ISH, both tests are very helpful to conﬁrm HPV
infection (IHC) and subsequent HPV typing (ISH).
In conclusion, this review is focused on the use of IHC
to identify viral pathogens that are relevant to dermatopathol-
ogy and on the usefulness of these techniques in the diagnosis
of cutaneous viral infections and other related diseases.
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CME Examination Part I
1. In cutaneous infections due to Herpes simplex virus, the strongest immunohistochemical staining is seen in the:
a. Lymphocytes of the inﬂammatory inﬁltrate
b. Apocrine glands epithelium
c. Eccrine glands epithelium
d. Outer root sheath of the hair follicle
e. Epidermal keratinocytes
2. In cutaneous early infections due to Varicella-zoster virus, the strongest immunohistochemical staining is seen in the:
a. Outer root sheath of the hair follicle
b. Sebocytes of the sebaceous gland
c. Epidermal keratinocytes
d. Nerves of the dermis
e. a and b
3. Epstein–Barr virus has been related to all the following diseases, except:
a. Infectious mononucleosis
b. Hairy leukoplakia in patients with AIDS
c. Nasopharyngeal lymphoepithelial carcinoma
d. Lymphoproliferative disorders
e. Epidermodysplasia verruciformis
4. In Kaposi’s sarcoma, with which of the following monoclonal antibodies will most lesional cells be immunoreactive?
a. LNA-1
b. VZV
c. CM5E1
d. Ab3
e. LMP1
5. In which of the following viral-related skin diseases are the histopathological ﬁndings not speciﬁc?
a. Trichodysplasia spinulosa
b. Kaposi’s sarcoma
c. Exanthema subitum
d. Orf
e. Merkel cell carcinoma
6. Which of the following HPV-immunohistochemical staining patterns has been suggested as a feature indicating progression
in the ﬁeld of cervical cancer?
a. Positive HPV-cytoplasmic immunoexpression
b. Lack of expression of major capsid protein L1
c. Lack of expression of major capsid protein L2
d. Expression of the minor capsid protein L2
e. Lack of expression of major and minor capsid proteins
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Background: Cutaneous viral infections are increasing in recent
years, particularly in immunocompromised patients.
Objective: Immunohistochemistry (IHC) provides a rapid and
helpful tool that can be applied to conﬁrm the diagnosis of speciﬁc
viral infections that may be difﬁcult to diagnose with certainty using
routine microscopy alone.
Methods: Several immunostains that are useful in histopathology
have been reviewed and tested in cutaneous samples of viral
infections. Emphasis is placed on new stains and novel uses of
existing stains.
Results: This article is an up-to-date overview of the potential uses
of IHC in the histopathologic diagnosis of cutaneous viral infections
by parvoviruses, polyomaviruses, poxviruses, paramyxoviridae,
picornaviridae, retroviruses, and ﬁloviruses.
Limitations: Speciﬁc monoclonal antibodies are commercially
available only for some members of these virus families.
Conclusions: IHC may assist dermatopathologists to appropriately
diagnose viral infections by parvoviruses, polyomaviruses, poxvi-
ruses, paramyxoviridae, picornaviridae, retroviruses, and ﬁloviruses.
Key Words: immunohistochemistry, virus, skin, infection, parvovi-
ruses, polyomaviruses, poxviruses, paramyxoviridae, picornaviridae,
retroviruses, ﬁloviruses
(Am J Dermatopathol 2014;0:1–11)
INTRODUCTION
In this part II of this review, we highlight the available
main immunohistochemical techniques that have been used and
continue to evolve in the diagnosis of mucocutaneous in-
fections caused by parvoviruses, polyomaviruses, poxviruses,
paramyxoviridae, picornaviridae, retroviruses, and ﬁloviruses.
MATERIALS AND METHODS
The biopsy specimens were ﬁxed in 10% buffered
formalin and embedded in parafﬁn. For routine histology,
5-mm-thick sections were stained with hematoxylin and eosin.
Immunohistochemical stains were performed both at the
Pathology Department of Fundación Jiménez Díaz University
Hospital in Madrid and the Dermatopathology Laboratory at
Friedrichshafen, Germany. Tissue sections were processed on
a BioTek Solutions TechMate 500 (Dako), where 1-hour incu-
bation with a primary antibody was performed. The immuno-
histochemical study of the viral pathogens was performed
using the commercially available antibodies. Several antibodies
for speciﬁc viruses described in the literature were not com-
mercially available at the time of elaboration of this manu-
script; therefore, immunohistochemical staining for these
pathogens could not be tested.
PARVOVIRUSES
The Parvoviruses are single-stranded DNA viruses and
among the smallest known DNA-containing viruses to infect
mammalian cells. Parvovirus B19 (PVB19), which belongs to
the genus Erythrovirus, is the only known human pathogen in
this family.1 Primary infection with PVB19 can be either
asymptomatic or bring about a number of clinical syndromes.
These include 2 speciﬁc PVB19-related dermatologic dis-
eases, erythema infectiosum (ﬁfth disease), and purpuric
“gloves-and-socks” syndrome (PPGSS). The most frequently
observed dermatological manifestation of PVB19 infection is
erythema infectiosum, while PPGSS is rare, and less than 100
cases have been reported.2 The histopathologic ﬁndings in
infectious erythema and PPGSS are nonspeciﬁc, and usually
consist of foci of epidermal spongiosis, with a superﬁcial
perivascular inﬁltrate mostly composed of lymphocytes and
some extravasated red cells.2
Demonstration of viral DNA in serum and/or skin biopsy
samples has been carried out in a handful of reports as a means
of linking PPGSS to PVB19 infection.3–5 However, it has
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become clear that PVB19 can persist for a long time in human
tissues,6 and viral DNA has been found in normal skin with
a frequency ranging from 22.5% to 76%.7,8 This raises the
issue whether PVB19 should be regarded as a true pathogen
or as an innocent bystander. However, PVB19 can be detected
immunohistochemically in the cytoplasm of endothelial cells of
congested capillaries in the papillary dermis in skin lesions in
PPGSS (Fig. 1) and infectious erythema using the anti-PVB19
monoclonal antibody directed against the viral protein
VP2.2,9,10 Therefore, immunohistochemical detection of
PVB19 in the endothelial cells of biopsy specimens performed
in the clinical setting of PPGSS and other related exanthemas
could be pathogenetically signiﬁcant and help in the under-
standing of these diseases.
PVB19 infects cells possessing the receptor for viral
entry, the P blood group antigen globoside, with help from
coreceptors alpha5beta1 integrin and Ku80.11 The distribution
of viral receptors in different tissues (erythroid progenitors,
endothelium, megakaryocytes, fetal myocytes, liver, lung,
kidney, synovium, and placental trophoblast) plays a signiﬁ-
cant role in the pathogenesis of the most frequent syndromes
related to PVB19 infection, which include transient aplastic
crises, anemia, fetal hydrops, ﬁfth disease, PPGSS, and
arthropathy. Santonja et al2 demonstrated PVB19 endothelial
positivity in several cases of PPGSS and proposed that the
immunohistochemical detection of PVB19 in the endothelial
cells of PPGSS suggests that PVB19 triggers an immunologic
response responsible for the histopathologic ﬁndings of peri-
vascular lymphocytic inﬂammation/lymphocytic vasculitis,
edema, and red blood cell extravasation.2 Moreover, involve-
ment of the endothelium by PVB19 is in keeping with the
expression of the viral receptor globoside by endothelial cells
and suggests that the exanthema results from a cytotoxic
T-cell reaction to virally infected cells. Other authors9,10 have
found PVB19 positive labeling not only of the endothelial
cells of the dermal vessels but also of the epithelium of
eccrine glands, ducts, and epidermal keratinocytes in biopsy
specimens of PPGSS.
Endothelial cell involvement by the virus has also been
investigated by PVB19 RNA expression in endothelium, by
reverse transcriptase in situ polymerase chain reaction (PCR)
and by immunohistochemistry (IHC) in the context of
vasculitis and autoimmune diseases.12 The subsequent immu-
nologic reaction has been linked not only with dermatologic
conditions (including scleroderma, adult Schönlein purpura,
and dermatomyositis)13–15 but also with systemic diseases,
such as systemic lupus erythematosus, myocarditis, and pul-
monary ﬁbrosis.16–18
POLYOMAVIRUSES
Polyomavirus (PyV) infections were accidentally dis-
covered in the 1950s when characterizing a transmissible agent
causing multiple tumors in rodents, hence providing the name
(Greek poly-multiple; -oma, tumors).19 Today the expanding
family of human PyV (HPyV) consists of 10 members, but
only 2 of them are important for dermatopathologists: the
recently identiﬁed Merkel cell polyomavirus (MCPyV) and
trichodysplasia spinulosa polyomavirus (TSPyV). Serological
studies suggest that HPyVs subclinically infect the general
population with rates ranging from 35% to 90%. However,
signiﬁcant disease is only observed in patients with impaired
immune functions.20
FIGURE 1. Histopathologic and immu-
nohistochemical findings in the cuta-
neous lesions of a patient with PPGSS.
A, Scanning power showing discrete
perivascular infiltrates in the superfi-
cial dermis. B, Higher magnification
demonstrated perivascular lympho-
cytes and extravasated red cells. C,
The same case immunohistochemi-
cally studied with the anti-PVB19
monoclonal antibody directed
against the viral protein VP2. D, Im-
munoexpression for PVB19 within the
cytoplasm of endothelial cells (A and
B, hematoxylin–eosin stain; C and D,
IHC for PVB19 antibody; original
magnifications: A ·10, B ·400, C
·10, and D ·400).
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Merkel Cell Polyomavirus
Merkel cell carcinoma (MCC) is a rare but aggressive
human skin cancer that typically affects elderly and immu-
nosuppressed individuals, a feature suggestive of an infec-
tious origin. The search for an infectious agent yielded
a major breakthrough in 2008; the discovery of the MCPyV
by means of digital transcriptome subtraction.21 Numerous
studies rapidly validated the association of MCC with this
virus that is integrated in the nuclei of MCC neoplastic
cells.22–24 Although the association between MCC and the
MCPyV is now well established, it is also clear that this virus
is not required for MCC as approximately 20% of these
tumors contain no detectable MCPyV. Moreover, it is clear
that MCPyV is not sufﬁcient for developing MCC because it
remains a rare cancer despite the fact that more than half of
adults have antibodies to MCPyV and hence were exposed to
the virus, typically in childhood.24,25 Finally, MCPyV is not
exclusive to MCC because it has also been observed rarely in
certain squamous cell carcinomas in immunosuppressed
patients.26,27
Since the original report, multiple studies have
demonstrated the clonal integration of MCPyV in the
nucleus of MCC cells in approximately 80% of the cases.
A variety of methods have been used to detect the presence
of the virus, including Southern blot analysis, PCR
ampliﬁcation of viral DNA, detection of integrated PyV
sequences, in situ hybridization, DNA sequencing by
hybrid capture, RT-PCR, and IHC with antibodies speciﬁc
for MCPyV large T antigen and small T antigen.24,28–30
Based on homology to other polyomaviruses, the MCPyV
large and small T antigens are predicted to be oncogenic
and contribute directly to the carcinogenesis of MCC.30
Shuda et al29 developed a monoclonal antibody
CM2B4 against a peptide fragment of the MCPyV T antigen
exon 2 to detect MCPyV oncoprotein expression in the
MCC tumor cells directly. The majority of the CM2B4-
positive tumors showed strong and diffuse nuclear labeling
in a large part of the tumor cell population (Fig. 2) and 77%
of the PCR-positive tumors were immunoreactive for
CM2B4. Later, these same authors31 reported that the
CM2B4 antibody failed to detect large T antigen in several
cases of MCC but that many of these negative specimens
stained positive with the monoclonal antibody CM5E1 speciﬁc
for MCPyV small T antigen. The combined use of CM2B4 and
CM5E1 led to detection of MCPyV T antigens in 47 (92%) of
51 cases of MCC, whereas CM2B4 alone detected large
T antigen in 75% of cases.
Recently, Rodig et al30 have performed IHC staining
with a newly developed mouse monoclonal antibody, Ab3,
that has markedly increased sensitivity in detecting
MCPyV large T antigen (97%) in MCC compared with
CM2B4 (80%). They propose that the presence of MCPyV
in MCC is more common than previously reported and that
improved detection methods may reveal that practically all
MCC specimens contain viral DNA of MCPyV. Ab3 does
not stain lymphocytes, even when used at higher concen-
trations or when staining tonsillar and reactive lymph node
tissue specimens. The lack of nonspeciﬁc staining may be
especially useful in clinical specimens because MCC
tumors frequently contain inﬁltrating lymphocytes.32
Furthermore, Ab3 did not stain tumor specimens from
gastrointestinal neuroendocrine tumors or small cell lung
cancer, supporting its usefulness as a clinical biomarker
for MCC.
FIGURE 2. Histopathologic and immu-
nohistochemical findings in a MCC. A,
Scanning power showing a neoplasm
that involved the full thickness of the
dermis and extended to subcutaneous
tissue. B, Higher magnification dem-
onstrated that the tumor was com-
posed of small round cells with
vesicular nuclei and multiple small
nucleoli. C, The same case im-
munohistochemically studied with the
monoclonal antibody CM2B4 against
a peptide fragment of the MCPyV. D,
Immunoexpression for CM2B4 is seen
in the nuclei of neoplastic cells (A and
B, hematoxylin–eosin stain; C and D,
IHC for CM2B4 antibody; original
magnifications: A ·10, B ·400, C ·10,
and D ·400).
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Several studies26,27 have shown that MCPyV DNA may
be identiﬁed by PCR in up to 70% of nonmelanocytic cuta-
neous neoplasms in immunocompetent and immunosup-
pressed patients. Unlike MCC, these skin tumors exhibit no
immunohistochemical evidence for intracellular viral anti-
gens. Inﬂammatory cells may have transported viral DNA
into peritumoral inﬁltrates as suggested by the fact that
inﬂammatory CD14+ CD162monocytes constitute a reservoir
for MCPyV.33 When interpreting MCPyV detection, it is
therefore essential to consider both molecular biology and
immunohistochemical results.
Trichodysplasia Spinulosa Polyomavirus
Trichodysplasia spinulosa (TS) is a folliculocentric skin
disorder that presents as keratotic spiny papules typically
distributed over the ears and structures of the central face and
less commonly involves the extremities, trunk, and scalp.
Alopecia, usually most severely affecting the eyebrows and
eyelashes, often accompanies the disorder. Haycox et al34, in
1999, were the ﬁrst authors using the term TS to describe friable
follicular spinous lesions in a patient who received a combined
renal/pancreas transplant. The authors showed, for the ﬁrst time,
the intracellular presence of virus particles with an appearance
that was interpreted by them as consistent with viral particles of
the Papovaviridae family. However, the original description of
this disorder was published by Izakovic et al, in 1995, when
they reported hair-like hyperkeratosis in patients with kidney
transplants and considered the process as a new cyclosporine
side-effect.35 Since then, several cases have been reported in
the literature20,36–67 under different names, including viral-
associated trichodysplasia,39,43,49,52,60 trichodysplasia of immu-
nosuppression,45 virus-associated TS,40 follicular dystrophy
of immunosuppression,37 cyclosporine-induced folliculodystro-
phy,38 pilomatrix dysplasia,36 and spiny hyperkeratosis
(hair-like hyperkeratosis).41 In 2010, van der Meijden et al46
identiﬁed a new HPyV (TSPyV) in plucked facial spines of
a heart transplant patient with TS, conﬁrming the PyV etiology
of this process.
The histopathologic ﬁndings are distinctive and consist
of distorted and dilated anagen hair follicles ﬁlled by sheets of
eosinophilic cells exhibiting the appearance of inner root
sheath cells.34,35 These cells, which contain abnormally large
trichohyaline granules, abruptly cornify without the presence
of a granular cell layer. The involved follicles, instead of the
full keratinization toward a mature hair shaft, appear replete
with sheets of nucleated cornifying cells that persist through-
out most of the lower segment of the hair follicles. The obser-
vation was made that pathogenesis seemed to be related to
immunosuppression, with the lesions resolving as immune
function returned to normal.
Several tools, including scanning electron microscopy,
PCR analysis of viral DNA, or immunohistochemical staining
for the PyV middle T antigen, have been used to identify the
pathogenic virus associated with TS. In the initial description
of viral-associated TS, immunohistochemical stains demon-
strated increased Ki-67 protein expression and negative
staining for Papillomavirus.34 At that time, the initial virus
was assumed to be part of the Papovaviridae family, which
has subsequently been split into the Papillomaviridae and
Polyomaviridae families. Most studies in TS have identiﬁed
TSPyV by electron microscopy,39,40,42,43,49,54,55,57 PCR stud-
ies,20,49,54,55,57,59,66 or immunoﬂuorescence,54 but very few
attempts have been performed by IHC.55,60 In the case
described by Fischer et al,55 immunohistochemical investiga-
tion for the HPyV middle T antigen with the SV40 antibody,
which recognized the NH2 terminus within amino acids 83–
128 of a large tumor antigen of SV-40 and JCV of PyVs, failed
to detect the virus in lesional skin, renal allograft, and urine
specimens.55 However, Wanat et al60 have recently described
immunohistochemical positivity with SV-40 antibody for
TSPyV in lesional skin of a patient with TS, demonstrating
positive staining of the large eosinophilic cellular inclusions
within keratinocytes composing the inner root sheath in all
the follicles examined in the patient’s samples, and we have
corroborated these ﬁndings (Fig. 3). These positive cellular
inclusions are visualized on both vertical and horizontal sec-
tions, and scanning electron microscopy conﬁrmed that these
inclusions contained small, icosahedral, regularly spaced, intra-
cellular viral particles consistent with PyV.60 These authors sup-
port that immunohistochemical staining for the middle T
antigen or other viral proteins may be a useful tool for the
identiﬁcation of this disease process and a potentially more use-
ful and practical way to establish the diagnosis compared with
PCR assay or electron microscopy.60 However, further cases are
required to verify the utility of immunohistochemical staining
because a negative result would not exclude the diagnosis.
Finally, routine testing with PCR assay, electron micros-
copy, or immunohistochemical stains is not necessary in all
cases because routine histologic staining can be sufﬁcient to
make the diagnosis in cases of classic clinical presentations.
Because the true incidence and clinical spectrum of this
recently recognized disease is not known, these tools may be
valuable in conﬁrming the diagnosis in cases involving more
subtle or atypical presentations. It is important that clinicians
are aware of all the potential evaluations that can be performed
and that they recognize the newly described HPyV as the
infectious agent that is responsible for TS.
POXVIRUSES
The family Poxviridae is divided into many genera, of
which the genus Orthopoxvirus includes vaccinia virus, var-
iola virus, cowpox virus, and at least 6 other species, includ-
ing monkeypox virus, camelpox virus, and raccoonpox
virus.68,69 Only 3 other genera cause human disease: the genus
Parapoxvirus causing milker’s nodule, orf, and sealpox69–71;
the genus/subgenus Molluscipoxvirus resulting in molluscum
contagiosum72; and the genus Yatapoxvirus resulting in tana-
pox. Skin infections caused by parapoxvirus have character-
istic histopathology.
Orf (Ecthyma Contagiosum)
Orf (ecthyma contagiosum) is primarily a disease of
young sheep and goats, involving the lips and perioral area.1 It
is caused by a poxvirus of the paravaccinia subgroup. Orf can
be transmitted to humans by contact with infected animals.
Lesions, which measure approximately 1–3 cm or more in
Molina-Ruiz et al Am J Dermatopathol  Volume 0, Number 0, Month 2014
4 | www.amjdermatopathology.com  2014 Lippincott Williams & Wilkins
Copyright ª Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
diameter, develop most commonly on the hands and forearms.
Spontaneous regression is usual approximately in 7–8 weeks.1
The diagnosis is based on case history (contact with
infected animals) and clinical features.73 Viral cultures, histo-
pathologic examination of biopsy specimens, electron micros-
copy, ﬂuorescent antibody tests, and identiﬁcation of speciﬁc
viral nucleic acid have all contributed to establish the diag-
nosis.73–76 Orf has a distinctive histological appearance of
hyperkeratosis and cell ballooning in the cells of the upper
layers of the epidermis. Eosinophilic intracytoplasmic inclu-
sions are seen within these ballooned cells. The lesions of orf
are generally regarded as histopathologically indistinguish-
able from milker’s nodules,77 although full-thickness epider-
mal necrosis seems to be more common in orf. Recently,
a monoclonal antibody against the ORFV059 protein encoded
by orf virus have been synthesized, which recognized the
ORFV-Jilin ORFV059 protein in a variety of immunological
assays, but to our knowledge, this antibody is not yet com-
mercially available.78
PARAMYXOVIRIDAE
Measles
Measles is a highly contagious viral disease caused by an
RNA virus of the Paramyxoviridae family, and human beings
are the natural host and reservoir of infection. It spreads through
the respiratory route and the virus tends to involve the lymph
nodes, followed by viremia and infection of any organ,
including the skin.79 The disease is characterized by fever, ma-
laise, cough, nasal congestion, conjunctivitis, and an erythem-
atous maculopapular skin rash that appears 3 or 4 days after the
onset of fever and spreads in a craniocaudal direction becoming
conﬂuent as the disease progresses. A pathognomonic enantem,
named Koplik spots, appears during prodrome and consists of
white papules on the oral mucosa. The disease is largely self-
limiting in immunocompetent and immunized individuals but
may be severe and even deadly in immunocompromised
patients. All countries in the World Health Organization have
renewed their commitment to eliminate measles transmission
by 2015. However, measles has re-emerged in Europe recently
because of suboptimal immunization levels that led to accumu-
lation of susceptible populations over the last years.80
From an histopathologic point of view, the ﬁndings in
skin rash of measles are usually nonspeciﬁc. Examination of
the biopsy specimen usually shows basal vacuolar degener-
ation and mild dermal lymphocytic inﬁltrate, which usually is
predominantly perifollicular. In some cases, multiple necrotic
keratinocytes in the superﬁcial epidermis, multinucleated
intraepidermal cells, and pyknotic keratinocytes in the hair
follicle epithelium have been described.81,82 In the skin and
oral mucous lesions (Koplik’s spots), multinucleated kerati-
nocytes with pyknotic nuclei have reported in the upper layers
of the epithelium,82,83 in the hair follicles,84 and in the acro-
syringium,85 and they have been proposed as a cytopathologic
clue for speciﬁc diagnosis. Intranuclear and intracytoplasmic
inclusion bodies and abundant eosinophils in the inﬁltrate
have been also described.86
Electron microscopic, immunoﬂuorescence, and immu-
nohistochemical studies have detected the measles virus in
lesional skin within endothelial cells of dermal capillaries,87
epidermal multinucleate cells,83 dermal ﬁbroblasts and macro-
phages,87 lymphocytes,84 keratinocytes of the upper layers of
the epidermis,84,88,89 hair follicles,84,88,90 and sebaceous
glands.88 IHC detects the measles virus–speciﬁc antigens with
a commercially available monoclonal antibody directed
FIGURE 3. Histopathologic and immu-
nohistochemical findings in cutaneous
lesions of a patient with TS. A, Scan-
ning power showing involvement of
all hair follicles present in the biopsy.
B, Higher magnification demon-
strated that the inner root sheath cells
contained abnormally large tricho-
hyaline granules. C, The same case
immunohistochemically studied with
the monoclonal antibody SV-40 for
TSPyV. D, Immunoexpression for
SV-40 is seen in the large trichohya-
line granules of the inner root sheath
cells (A and B, hematoxylin–eosin
stain; C and D, IHC for SV-40 anti-
body; original magnifications: A ·10,
B ·400, C ·10, and D ·400).
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against the viral nucleoprotein90 (Fig. 4). It has also been
demonstrated that wild-type strains of measles virus use the
signaling lymphocyte activation molecule (SLAM, also
named CDw150) as a cellular receptor. In contrast, laboratory
strains of measles virus and its derivate vaccine strains use
both SLAM and the complement regulatory protein CD46 as
cellular receptors.91 Immunohistochemical studies of the skin
of measles patients using monoclonal antibodies anti-SLAM
and anti-CD46 have shown that hair follicles, epidermis, cap-
illary blood vessels, ﬁbroblasts, mononuclear cells, and acro-
syringium were CD46 positive and SLAM negative.90,92
These results suggest that CD46 may be a receptor of the
wild measles virus in the skin.90,93
PICORNAVIRIADE
Enteroviruses
Enteroviruses comprise a subgroup of Picornaviridae
family that cause a wide spectrum of disorders associated
with exanthemas. The non-polio enteroviruses include echo-
viruses and coxsackie types A and B. These viruses have
a single-stranded RNA genome and an unenveloped capsid.
Enteroviral infections are worldwide infections trans-
mitted by fecal–oral or respiratory route. Enteroviruses ﬁrst
infect epithelial cells of the upper airway or lower alimentary
tract, replicate in lymph nodes, and disseminate by an initial
viremia. Subsequently, replication occurs in many organs and
during this replication period is when clinical manifestations
appear. A second and major viremia occurs during this period
or viral replication occurs in the secondary infection sites.94
Hand-foot-and-mouth disease (HFMD) is the most
characteristic exanthematous disease caused by enteroviruses.
Numerous coxsackie serotypes have been implicated, coxsackie
A16 being the most common etiologic factor. Prodromos
consist of fever and malaise and few days later the exanthema
appears. Dermatologic manifestations are characterized by the
abrupt onset of elongated ovoid small vesicles on the palms and
soles, in conjunction with erosive stomatitis. In rare cases,
vesicles may also involve dorsum of the hands and feet and
other nonacral areas of the skin. Most patients with HFMD have
a benign and self-limited course, although in rare cases of
outbreaks of severe enterovirus 71 infection, cardiopulmonary
and neurologic complications and even death of involved
patients have been described.95
Herpangina is a pediatric febrile disease cause by
coxsackie virus groups A and B or echoviruses characterized
by painful vesicles and erosions in buccal mucosa, soft palate,
and tonsils.96 Enteroviruses may also be the etiologic agent for
the so-called eruptive pseudoangiomatosis, which consists of
spontaneously regressing vascular papules composed of telan-
giectatic vessels, but without a proliferative component.97,98
Histopathologically, HFMD lesions show intraepidermal
vesicles with prominent reticular degeneration and a few
ballooned cells. No multinucleate cells or inclusion bodies
have been described in lesions of HFMD. Usually, there is
accompanying papillary dermal edema and a mild perivascular
inﬂammatory inﬁltrate mostly composed of lymphocytes.
Electron microscopic studies demonstrate viral particles.99 From
an immunohistochemical point of view, there is a commercially
available antibody that reacts with an epitope on the VP1 pep-
tide, which is highly conserved within the enterovirus group.100
FIGURE 4. Histopathologic and immu-
nohistochemical findings in the exan-
thema of patient with measles. A,
Scanning power showing apparently
normal skin. B, Higher magnification
demonstrated isolated necrotic kera-
tinocytes in the epidermis and mild
superficial perivascular lymphocytic
infiltrate. C, The same case im-
munohistochemically studied with
the antibody for measles virus. D,
Immunoexpression is seen in the
nuclei of epidermal keratinocytes,
keratinocytes of the hair follicle, and
lymphocytes of the dermal infiltrate
(A and B, hematoxylin–eosin stain; C
and D, IHC for measles antibody;
original magnifications: A ·10,
B ·400, C ·10, and D ·200).
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This antibody reacts with a molecule of 34–37 kDa molecular
weight, and it was generated by using coxsackie B5 as immu-
nogen. It reacts with most enteroviruses of echovirus, coxsackie
and poliovirus group, but does not react with rotavirus, yellow
fever virus, measles, rhinovirus A1, adenovirus 18, or hepatitis
A virus.101 In our experience, this generic anti-enterovirus anti-
body stains mostly keratinocytes of the acrosyringium in
lesional skin (Fig. 5).
RETROVIRUSES
Human T-Cell Lymphotropic Virus Type 1
Human T-cell lymphotropic virus type 1 (HTLV-1), also
named human T-cell leukemia virus type 1 and adult T-cell
lymphoma virus type 1, is endemic in the south of Japan and in
the Caribbean Islands and rare in other regions. Transmission
of HTLV-1 occurs primarily by sexual intercourse, blood
transfusions, needle sharing among intravenous drug abusers,
and breastfeeding. HTLV-1 induces T-cell proliferation, fol-
lowed by interleukin (IL)-2 receptor exposition, increased IL-2
secretion, and induction of interferon-g, IL-5, and IL-10.
HTLV-1 is associated with infective dermatitis and
adult T-cell leukemia/lymphoma (ATLL). Infective dermatitis
is an exudative and eczematous dermatosis that involves
mostly the scalp, axillae, groin, and small folds of the face.102
In some cases, infective dermatitis may progress to more
severe HTLV-1–associated disease, such as ATLL. Four
variants of ATLL are recognized in the new World Health
Organization classiﬁcation of tumors of hematopoietic and
lymphoid tissues103: acute and chronic leukemic, lymphoma-
tous, and smoldering types. Although cutaneous manifesta-
tions are usually seen in the smoldering form of the disease, it
has been suggested that patients with purely cutaneous lesions
may have a better prognosis and should be classiﬁed sepa-
rately from those with smoldering ATLL.104 Cutaneous man-
ifestations and histopathologic features of ATLL are identical
to those of mycosis fungoides, so demonstration of retroviral
infection is mandatory for diagnosis. Molecular analyses
show a monoclonal rearrangement of the TCR gene and the
presence of the integrated genome of HTLV-I.105 In the early
phase of the ATLL, neoplastic cell properties dependent
on the HTLV-1 proviral DNA pX region p40Tax protein
(Tax)101–109 appear under the effects of external and internal
mutagens110–112 following the accumulation of mutations
induced by repeated Tax expression113 in the background of
persistent proliferation of HTLV-1–infected T cells, which is
probably induced by HTLV-1 basic leucine zipper (HBZ)
messenger RNA.114,115 Then, late-phase ATLL cells with
neoplastic properties independent of Tax appear when muta-
tion has progressed in the host cell DNA and HTLV-1 pro-
viral DNA, including pX p40Tax DNA sequence.110
Histopathological diagnosis of ATLL is expected based on
IHC detecting of Tax, HTLV-1 proviral DNA pX p27Rex
protein (Rex), or HBZ messenger RNA/protein in neoplastic
cells116 (Fig. 6).
FIGURE 5. Histopathologic and immu-
nohistochemical findings in cutaneous
lesions of a patient with HFMD. A,
Scanning power showing severe epi-
dermal involvement. B, Higher magni-
fication demonstrated intraepidermal
vesicle with prominent reticular degen-
eration and a few ballooned cells. C,
The same case immunohistochemically
studied with the monoclonal anti-
body that reacts with the VP1 peptide
of the enterovirus group. D, Im-
munoexpression for VP1 peptide of
the enterovirus group is seen in epi-
dermal keratinocytes and acrosyr-
ingeal keratinocytes (A and B,
hematoxylin–eosin stain; C and D,
IHC for enterovirus antibody; original
magnifications: A ·10, B ·40, C ·10,
and D ·200).
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FILOVIRUSES
The family Filoviridae is an unique negative-stranded
RNA virus family that forms ﬁlamentous virions. Not much is
known about ﬁloviruses because their highly pathogenic
nature makes them difﬁcult to study. Two members of the
family that are commonly known are Ebola virus and
Marburg virus.117 Both viruses, and some of their lesser
known relatives, cause severe disease in humans and nonhu-
man primates in the form of viral hemorrhagic fevers.
Ebola Virus
Ebola virus causes a severe and often fatal hemorrhagic
fever.117 Ebola hemorrhagic fever (EHF) is a rare disease, and
the number of sporadic cases occurring in tropical Africa is
unknown. The clinical diagnosis of EHF is often presumptive,
and laboratory conﬁrmation is essential. Traditionally, the
laboratory diagnosis of EHF has been accomplished through
virus isolation or serologic assays.118,119 Because of the bio-
safety hazards associated with the handling and testing of
EBO virus, these assays can be performed in only a few
specialized laboratories worldwide, requiring transportation
of the dangerous biological specimens from remote sites to
these laboratories.
In 1999, Zaki et al120 reported the development of
a novel, safe, sensitive, and speciﬁc diagnostic immunohisto-
chemical test for Ebola virus infections, which uses formalin-
ﬁxed postmortem skin specimens, and should be useful for
EHF surveillance and prevention. This antibody is not com-
mercially available. These authors evaluated skin biopsies of
14 patients during the EHF outbreak in the Democratic
Republic of Congo in 1995. They found abundant viral anti-
gens and particles within endothelial cells, mononuclear
phagocytic cells, and ﬁbroblasts in the skin of EHF patients
using IHC, thus suggesting an epidemiologic role for contact
transmission. Histopathologic changes in the skin tissue were
not pathognomonic and consisted mainly of various degrees
of endothelial cell swelling and necrosis.
CONCLUSIONS
IHC is an excellent diagnostic technique with the
distinct advantage of being able to exactly locate a given
protein within the tissue examined. The ﬁeld is continu-
ously expanding, with new applications steadily increas-
ing. Ultimately, the possibilities of IHC in the ﬁeld of
cutaneous viral infections are immense, and the future is
very promising.
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APPENDIX CME Examination
1. Which of the following entities are PVB19-related derma-
tologic diseases?
a. Erythema infectiosum (ﬁfth disease)
b. Roseola infantum
c. Purpuric “gloves-and-socks” syndrome (PPGSS)
d. b and c
e. a and c
2. To which of the following diseases has Merkel cell poly-
omavirus been related?
a. Squamous cell carcinoma
b. Merkel cell carcinoma
c. Melanoma
d. a and b
e. b and c
3. Immunohistochemical studies have detected the measles
virus in lesional skin within endothelial cells of:
a. Dermal capillaries
b. Epidermal multinucleate cells and lymphocytes
c. Keratinocytes of the upper layers of the epidermis
d. Hair follicles and sebaceous glands
e. All of the above
4. Hand-foot-and-mouth disease (HFMD) is an exanthema-
tous disease caused by:
a. Herpes viruses
b. Papillomaviruses
c. Poxviruses
d. Enteroviruses
e. Parvoviruses
5. Which of the following monoclonal antibodies has proved
higher sensitivity in detecting MCPyV large T antigen
when used in skin biopsy specimens?
a. CM2B4
b. LNA-1
c. CM5E1
d. Ab3
e. LMP1
6. Trichodysplasia spinulosa has been recently associated
with a new virus included in the family of:
a. Herpesviridae
b. Papillomaviridae
c. Polyomaviridae
d. Parvoviridae
e. Poxviridae
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Immunohistochemistry in the Diagnosis of
Cutaneous Bacterial Infections
Ana María Molina-Ruiz, MD,* Lorenzo Cerroni, MD,† Heinz Kutzner, MD,‡ and Luis Requena, MD*
Abstract: The identiﬁcation of pathogens is of vital importance for the
adequate treatment of infections. During the past 2 decades, the
approach to histopathologic diagnosis has been dramatically transformed
by immunohistochemistry (IHC) speciﬁcally in the diagnosis and
classiﬁcation of tumors and more recently in the diagnosis of infectious
diseases in tissue samples. The main goals of this article were to: (1)
identify by IHC the cutaneous structures where bacterial pathogens are
expressed in the course of infection, (2) identify the speciﬁc cells in
which bacterial pathogens are expressed in positive cases, and (3)
describe the pattern of distribution of the bacterial antigens within these
cells (nuclear, cytoplasmatic, or membranous). This article is an up-to-
date overview of the potential uses and limitations of IHC in the
histopathologic diagnosis of cutaneous bacterial infections. In conclu-
sion, IHC is especially useful in the identiﬁcation of microorganisms
that are present in low numbers, stain poorly, are fastidious to grow,
culture is not possible, or exhibit an atypical morphologyAU4 .
Key Words: immunohistochemistry, bacteria, skin, infection, pyo-
genic bacteria
(Am J Dermatopathol 2014;00:1–16)
LEARNING OBJECTIVES
Upon completion of this learning activity, participants
should be better able to:
1. Use immunohistochemistry (IHC) to identify bacterial
pathogens that are relevant to dermatopathology.
2. Apply these techniques in the diagnosis of cutaneous bac-
terial infections and other related diseases.
INTRODUCTION
Traditionally, microbial identiﬁcation in infectious dis-
eases has been made primarily by using serologic assays and
cultures. However, serologic results can be difﬁcult to interpret
in the setting of immunosuppression or when only a single
sample is available for evaluation. In addition, fresh tissue is
not always available for culture, and culture of certain
pathogens can be difﬁcult and may take weeks or months to
yield results. Moreover, culture alone cannot distinguish
colonization from tissue invasion. Some microorganisms have
distinctive morphologic characteristics that allow their identi-
ﬁcation in formalin-ﬁxed and parafﬁn-embedded (FFPE)
tissues using routine and special stains. Nevertheless, in several
instances, especially when the number of microorganisms is
sparse, it is difﬁcult or even impossible to identify an infectious
agent speciﬁcally by conventional morphologic methods.
Immunohistochemistry (IHC) has become an excellent tool
in the diagnosis of cutaneous infections and plays an important
role in recognizing infectious agents in tissue samples from
patients, providing a rapid morphologic diagnosis and facili-
tating clinical decisions in patient treatment.
IHC uses antigen–antibody recognition in detecting spe-
ciﬁc antigens within tissues. The term covers a group of
immunostaining techniques in which labeled antibodies are used
to detect the presence of antigens in cells or tissues. The prin-
ciple of IHC lies in the ability of antibodies to bind speciﬁcally
to their respective antigens. The resulting reaction can only be
visualized when the antibody is labeled with a substance that
absorbs or emits light or produces color. Due to the technical
advances, there has been a signiﬁcant increase in the number of
diagnostic IHC stains available for pathologists and dermatopa-
thologists in recent years. The sensitivity and speciﬁcity of cer-
tain antibodies, their pattern of staining (nuclear, cytoplasmic,
membranous, or different combinations of them), and the back-
ground artifact must be considered in their interpretation.
This article is an up-to-date overview of the potential
uses and limitations of IHC in the histopathologic diagnosis of
cutaneous bacterial infections. Emphasis is placed on new
stains and novel uses of existing stains. For this purpose, we
have studied several immunostains for speciﬁc bacteria that can
be useful in dermatopathology focusing on 3 major objectives:
1. Identify by IHC the cutaneous structures where bacterial
pathogens are expressed in the course of infection.
2. Identify the speciﬁc cells in which bacterial pathogens are
expressed in positive cases.
3. Describe the pattern of distribution of the bacterial anti-
gens within these cells (nuclear, cytoplasmatic, membra-
nous, or combinations of them).
MATERIALS AND METHODS
The biopsy specimens were ﬁxed in 10% buffered
formalin and embedded in parafﬁn. For routine histology,
5-mm-thick sections were stained with hematoxylin and
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eosin. IHC stains were performed both at the Pathology
Department of Fundación Jiménez Díaz University Hospital
in Madrid and the Dermatopathology Laboratory at
Friedrichshafen, Germany. Tissue sections were processed
on a BioTek Solutions TechMate 500 (Dako) where 1-hour
incubation with a primary antibody was performed. The
IHC study of the bacterial pathogens was performed using
the commercially available antibodies described inT1 Table 1. In
that table we also include the cross-reactivity with other micro-
organisms of some of these antibodies. Several antibodies for
speciﬁc bacteria described in the literature are not commer-
cially available at the time of elaboration of this manuscript;
therefore, IHC staining for these pathogens could not be tested.
BACTERIAL PATHOGENS
Bacterial isolation is an important diagnostic tool in
patients with skin and soft tissues infections, but culturing these
tissues can be problematic. Sometimes, the isolation of certain
bacteria can merely indicate colonization and the failure to isolate
an organism may occur because of previous antibiotic treatment,
suboptimal handling of specimens, or variable growth require-
ments.1 IHC assays for bacteria are morphology-based techniques
that use FFPE samples and can help deﬁne the pathogenic role of
various microorganisms in the context of soft tissue infections.2
IHC on skin biopsy specimensAU5 has been shown through
several studies to be useful in diagnosing cutaneous infections
caused by pyogenic bacteria, Clostridium species, Bacillus an-
thracis, mycobacteria, spirochetes, rickettsiae, Neisseria, Chla-
mydia, Bartonella, Helicobacter, Tropheryma, etc. However,
not all immunostains for these pathogens are commercially
available nowadays because some of these stains have only
been developed in private institutions for research purposes.
In some cases, routine and/or histochemical staining is sufﬁ-
cient for diagnosis, and sometimes other laboratory methods
may be more sensitive and cost-efﬁcient. It is also important to
remember that there may be common antigens among bacteria
and pathogenic fungi and both monoclonal and polyclonal anti-
bodies must be tested for possible cross-reactivity with other
microorganisms (Table 1).
By using IHC assays for bacteria, we are able to
identify intact bacteria and granular antigen staining. In some
of these infections, particularly if antibiotic therapy has been
given, bacterial antigens can be more abundant than intact
bacteria, and in some cases, antigens can be the only evidence
of the causative infectious agent. Interpretation of IHC assays
may be difﬁcult in cases where granular antigens are observed
without intact bacteria, but in the appropriate clinicopatho-
logic and epidemiological setting, granular antigen staining
may be of important diagnostic value.3
PYOGENIC BACTERIA
Pyogenic infections, usually caused by Staphylococcus
aureus and strains of Streptococcus, are numerically the most
important bacterial infections of the skin.4 Two distinct groups
of pyogenic infections (superﬁcial and deep) can be distin-
guished on the basis of the anatomic level of involvement of
the skin. The pyogenic infections, with the exception of the
staphylococcal “scalded skin” syndrome, which results from
the effects of a bacterial exotoxin, are characterized histologi-
cally by a heavy inﬁltrate of neutrophils. These microorganisms
may also infect hair follicles, resulting in folliculitis. Furuncles
are deep-seated acute infections based on the folliculosebaceous
TABLE 1. Available Antibodies for Specific Bacteria Useful in Dermatopathology
Antibody Against Type/Clone
Staphylococcus aureus Anti-S. aureus, KPL BacTrace, polyclonal, goat; Medac
Streptococcus pyogenes (group A) Anti-Streptococcus A, polyclonal, rabbit; Biorbyt
Clostridium species Noncommercially available
Bacillus anthracis Anti-anthrax PA/anthrax LF, polyclonal, rabbit; Xceltis
Mycobacterium bovis BCG (cross-reacts with other Mycobacterium species, including
M. tuberculosis, M. leprae, M. avium, M. phlei, and M. parafortuitum)
Anti-M. bovis BCG, polyclonal, rabbit; DAKO
Mycobacterium tuberculosis (cross-reacts with otherMycobacterium species, including
M. leprae, M. avium, M. phlei, and M. parafortuitum)
Anti-M. tuberculosis, polyclonal, rabbit; Zytomed Systems
Treponema pallidum (cross-reacts with Borrelia burgdorferi) Anti-T. pallidum, polyclonal, rabbit; Zytomed Systems
Borrelia burgdorferi (Lyme disease) (cross-reacts with T. pallidum, Borrelia hermsii,
Borrelia parkeri)
Anti-Borrelia, polyclonal, rabbit; Biogenesis
Borrelia species (speciﬁc for B. burgdorferi, B. hermsii, Borrelia anserina, and
Borrelia coriaceae)
Anti-Borrelia species, KPL BacTrace, polyclonal, goat; Medac
Listeria species (cross-reacts with Streptococcus and Staphylococcus) Anti-Listeria species, KPL BacTrace, polyclonal, goat; Medac
Chlamydia trachomatis (cross-reacts with Chlamydia pneumoniae, Chlamydia psittaci) Anti-C. trachomatis, monoclonal (BDI815), mouse; Acris Antibodies
Bartonella henselae Anti-B. henselae, monoclonal (H2A10), mouse; Zytomed Systems
Bartonella quintana Anti-B. quintana; Xceltis
Rickettsia rickettsii; Rickettsia akari Noncommercially available
Tropheryma whipplei Noncommercially available
Neisseria meningitidis Anti-N. meningitidis, polyclonal, rabbit; Thermo Fisher Scientiﬁc
Neisseria gonorrhoeae Anti-N. gonorrhoeae, polyclonal, rabbit; Xceltis
Helicobacter pylori Anti H. pylori, KPL BacTrace, polyclonal, goat; Medac
Francisella tularensis Noncommercially available
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unit and adjacent dermis. IHC assays are useful for identiﬁca-
tion of pyogenic bacteria on FFPE samples of inﬂammatory
soft tissue lesions and complement culture results by morpho-
logically detecting the organism in areas with inﬂammation,
which, in conjunction with the clinical features, will help deﬁn-
ing if the microorganism is a pathogen or a commensal.
Staphylococcus aureus
Guarner et al2 studied the application of IHC assays for
S. aureus in FFPE tissue samples from patients with severe
soft tissue infections. For this purpose, they used both a mono-
clonal anti-S. aureus IgG3 antibody (QED Bioscience, Inc),
that reacted against the peptidoglycan of S. aureus (F1 Fig. 1)
and a polyclonal anti-S. aureus antibody (Biodesign) that
reacted with S. aureus but did not cross-react against group
A Streptococcus (GAS), group B Streptococcus, Streptococ-
cus pneumoniae, B. anthracis, Clostridium species, Klebsiella
pneumoniae, Pseudomonas aeruginosa, or Neisseria meningi-
tidis. By using IHC, they demonstrated bacteria and bacterial
antigens in phagocytic cells at the portal of entry, including the
affected skin, subcutaneous tissue, fascia, or muscle, indicating
that the host had mounted an inﬂammatory reaction against the
infectious agent and thus suggesting that the microorganism is
a pathogen rather than just a commensal. They also studied the
concordance of culture and IHC assay results in samples from
20 patients and found that S. aureus antigens were identiﬁed
by IHC in wound tissues from 3 patients while only 1 of these
3 patients had positive cultures for S. aureus.
Group A Streptococcus
Streptococcus pyogenes (GAS) is the most frequent bac-
terial cause of tonsillitis, pharyngitis, and skin and soft tissue
suppurative infections. Diagnosis of GAS infections is made
when S. pyogenes is isolated from pus or body ﬂuids. Strepto-
coccus pyogenes might not be isolated if antibiotics were admin-
istered before culture samples were obtained or if symptoms are
secondary to toxin production. Furthermore, samples often are
not obtained for patients who die before seeking medical care. If
autopsy or other specimens are available, diagnostic techniques
that use FFPE samples and do not require viable bacteria, such as
IHC or polymerase chain reaction (PCR), can be of great value.5
Guarner et al5 were the ﬁrst authors to report IHC
assays for GAS using a polyclonal rabbit antibody against
S. pyogenes (Biologics Branch, Centers for Disease Control)
on FFPE tissue specimens from 122 patients with clinically or
pathologically suspected GAS infection. Twenty-six cases of
122 patients showed IHC positivity for GAS, 5 of them hav-
ing a mucocutaneous primary focus. Affected skin or mucosa
from GAS infection showed various amounts of neutrophilic
inﬂammation, marked edema, and necrosis of the dermis or
submucosa, and adipose tissue septa. In these cases, GAS
antigens were demonstrated in the surface and deep tissues.
IHC showed the advantage of determining the distribution of
cocci and GAS antigens, preserving morphologic features,
and enabling a better understanding of how S. pyogenes
caused the disease. Also, detection of GAS in the context
of the morphologic features of tissue was helpful for deter-
mining the primary focus of infection and deﬁning systemic
spread of the disease, by localizing the bacteria in blood
vessels of a variety of tissues. In addition, identiﬁcation of
streptococci inside inﬂammatory cells indicated that systemic
spread occurred while the patient was alive rather than after
death. Sometimes GAS may be found in superinfected preex-
isting lesions ( F2Fig. 2).
FIGURE 1. Histopathologic and
immunohistochemical findings in
a dermal abscess caused by Staphy-
lococcus aureus. A, Scanning power
showing nodular infiltrates in the
dermis. B, Higher magnification
showed suppurative granuloma. C,
The same case immunohistochemi-
cally studied with monoclonal anti-
body against S. aureus. D, Higher
magnification showed numerous
positive microorganisms at the cen-
ter of the suppurative granuloma.
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CLOSTRIDIUM SPECIES
Anaerobic spore-forming bacilli of the genus Clostridium
are ubiquitous in the environment, existing in the form of exo-
spores that may remain viable indeﬁnitely. The genus Clostrid-
ium contains several species of known potential pathogenicity
for man and animals, including the gas gangrene group Clos-
tridium perfringens, Clostridium septicum, Clostridium sordel-
lii, Clostridium novyi and Clostridium histolyticum. The
contamination of wounds or illicit substances used by injecting
drug users with clostridial species may result in gas gangrene
(clostridial myonecrosis), leading to severe illness or death.1
IHC can be of great diagnostic value, particularly for
bacteria such as Clostridium species, which are difﬁcult to
isolate because of their anaerobic fastidious growth require-
ments. Guarner et al2 studied the application of IHC assays
for Clostridium species on FFPE tissue samples from patients
with severe soft tissue infections. For this purpose, they used
the anti-Clostridium species antibody (Biodesign) that reacted
with FFPE samples of C. difﬁcile, C. novyi, C. perfringens, and
C. sordellii but did not show reactivity on FFPE samples in-
fected by GAS, group B Streptococcus, B. anthracis, Bacillus
cereusAU6 , Enterococcus species, S. aureus, S. pneumoniae, Lis-
teria monocytogenes, Escherichia coli, K. pneumoniae, or
P. aeruginosa. They found that necrosis was frequently
observed in clostridial IHC-positive cases (83%), and the IHC
staining was focal and predominantly seen in areas with necro-
sis, edema, and inﬂammation. Clostridial IHC staining was
primarily found in the portal of entry, whereas systemic bacte-
rial presence was only documented as granular antigen staining
in a locally draining lymph node, further supporting the role of
toxins as the cause of systemic symptoms that can be present in
patients with clostridial infections. Also, clostridial bacilli and
clostridial antigens were observed inside inﬂammatory cells.
However, the broad reactivity of the antibody against multiple
Clostridium species has to be interpreted in the context of clin-
ical and histopathologic ﬁndings because nonhistotoxic clostri-
dia are components of the normal ﬂora present on the skin and
the gastrointestinal tract of humans.
Finally IHC assays have also been used to detect toxins,
and some authors have localized the C. perfringens b2 toxin in
the gastrointestinal tract of horses dying from typhlocolitis.6
BACILLUS ANTHRACIS
Cutaneous anthrax accounts for 95% of all naturally
occurring B. anthracis infections in the United States.6 Patients
often have a history of occupational contact with animals or
animal products contaminated with B. anthracis spores. These
pathogenic spores are introduced through a cutaneous cut or
abrasion, with the most common areas of exposure being the
head, neck, and extremities. Bacteremia and toxemia following
cutaneous infection can occur with a fatality rate of 20%–25%
among untreated cases.7 The clinical diagnosis traditionally has
been established by conventional microbiological methods, such
as culture and Gram staining. However, these methods often
yield negative results when patients have received antibiotics.
Shieh et al8 described the histopathologic features and the
IHC ﬁndings of bioterrorism-related cutaneous anthrax cases of
2001 and compared the results of IHC assays with other labora-
tory diagnostic methods, including culture, special stains, PCR,
and serology. For this purpose, the authors developed a colorimet-
ric immunoalkaline phosphatase IHC method by using 2 mono-
clonal antibodies: (1) a mouse monoclonal IgM antibody reactive
with B. anthracis cell wall antigen at 1:200 dilution (USA Mil-
itary Research Institute of Infectious Disease) and (2) a mouse
monoclonal IgM antibody reactive with B. anthracis capsule
FIGURE 2. Immunohistochemical
findings in a cutaneous SCC super-
infected by Streptococcus pyogenes.
A, Scanning power showed a well-
demarcated crateriform neoplasm.
B, Granular material and colonies of
S. pyogenes were present in the
central necrotic areas. C, Positive
granular material and colonies of
microorganisms are identified with the
specific antibody against S. pyogenes.
D, Higher magnification of a colony of
S. pyogenes.
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antigen at 1:1000 dilution. IHC staining revealed B. anthracis
antigens in 80% of the cases, and all of them were positive by
using both anti–cell wall and anti-capsule antibody. Extracellular
bacilliform and granular antigens were distributed in both epider-
mis and dermis. Intracellular immunostaining was also observed
in histiocytic cells and usually more prominent by anti-capsule
antibody. The authors conclude that because IHC testing of skin
biopsies can detect bacterial antigens in tissues regardless of the
treatment, it provides a more sensitive and speciﬁc way to estab-
lish the diagnosis of cutaneous anthrax compared with other tests,
including serology, culture, special stains, and PCR assay.
MYCOBACTERIAL INFECTIONS
The cutaneous mycobacterioses include tuberculosis (TB)
and leprosy, as well as a diverse group of infections caused by
various environmental (atypical, nontuberculous) mycobacteria.
Mycobacterium bovis Antibody (B124)
IHC staining with antibodies against M. bovis, the anti-
bacillus Calmette–Guérin (BCG) polyclonal antibody (B124)
proved to be an extremely valuable screening tool for the detec-
tion of bacteria or fungi in skin biopsy specimens. Original
studies demonstrated that it recognized all mycobacteria and
practically all gram-positive and gram-negative bacteria, as well
as the spores and hyphae of dermatophytes and other fungi,
whereas it did not recognize leishmaniasis or viral infections. It
could perhaps be said that immunostaining with anti-BCG anti-
body produces similar results to those achieved with the com-
bined use of Gram and periodic acid–Schiff (PAS) staining.9
Several studies showed that polyclonal anti-BCG anti-
bodies cross-react with a broad spectrum of microorganisms. In
1972, Minden et al10,11 ﬁrst demonstrated shared antigens
between M. bovis (BCG) and other bacterial species. In 1979,
Harboe et al,12 demonstrated cross-reactions between M. bovis
BCG and various other mycobacteria, Nocardia asteroides,
Corynebacterium pyogenes and L. monocytogenes. Later, Morris
et al13 identiﬁed antigenic determinants onM. bovis using mono-
clonal antibodies and found that the epitopes of mycobacterial
antigens were similar to epitopes from other bacterial species. In
the latter investigations, anti-BCG antibodies were successfully
used for IHC detection of the most common cutaneous microbial
pathogens in FFPE human tissue samples.14,15
In 1998, we studied a total of 254 FFPE skin specimens
known to contain different species of microorganisms using
a polyclonal rabbit anti-M. bovis (BCG) antibody (Dako code
#B124; lot 063; titer 1:6000)15 and demonstrated that anti-
BCG labeled a wide spectrum of fungal and bacterial organ-
isms with a high sensitivity and minimal background staining
( F3Fig. 3) but did not cross-react with viruses, spirochetes, and
protozoa. Regular skin structures, cellular debris, and necrotic
material were not immunostained by anti-BCG, in contrast to
most histochemical methods. In cases of fungal or bacterial
infection, the results of the anti-BCG immunostain were
clearly superior to those achieved with the conventional his-
tochemical stains. Because of its minimal background stain-
ing, the anti-BCG immunostain was especially helpful in
those cases in which few organisms were obscured by a dense
overlying inﬂammatory inﬁltrate or in cases with scant micro-
organisms like panniculitis. Also, by labeling bacteria in the
cytoplasm of polymorphonuclear granulocytes, it was possi-
ble to differentiate bullous impetigo from superﬁcial pemphi-
gus. However, because anti-BCG also labels physiologic skin
ﬂora (ie, mostly bacteria and pityrosporum in the follicular
FIGURE 3. Histopathologic and
immunohistochemical findings in
a case of ecthyma gangrenosum
caused by Pseudomonas aeruginosa.
A, Scanning power showed dilated
and congestive vessels at different
levels of the dermis. B, Higher mag-
nification demonstrated bluish
granular material within the lumina
of some vessels. These bluish gran-
ules corresponded to abundant
bacteria of P. aeruginosa. C, The
same case immunohistochemically
stained with the anti-BCG polyclonal
antibody (B124). D, Higher magni-
fication demonstrated numerous
bacteria of P. aeruginosa with strong
immunostaining with anti-BCG
antibody.
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infundibulum), this ﬁnding should not be overinterpreted as
clinically signiﬁcant.
Finally, this antibody has also proven to be useful in
veterinary dermatopathology16,17 and was found to be superior to
histochemical staining methods as a general screening tool in
cases where pathologic lesions suspicious for infections are evi-
dent and no microorganism can be cultured in vitro or only FFPE
tissue samples are available for the laboratory examination.
However, due to overpuriﬁcation by the manufacturer
in recent years, B124 is no longer an “antibody for all sea-
sons” that may be used for screening of bacterial and fungal
infections, replacing the PAS and Gram staining, as originally
was proposed, and currently the potential use of commercially
available anti-BCG antibody should be restricted to the search
of mycobacteria in FFPE samples.
Mycobacterium tuberculosis Complex
Mycobacterium tuberculosis complex members are causa-
tive agents of human and animal TB. Species in this complex
includeM. tuberculosis, the major cause of human TB, and many
other mycobacteria, such as M. bovis, M. bovis BCG, Mycobac-
terium africanum, Mycobacterium canetti, Mycobacterium cap-
rae, Mycobacterium microti, and Mycobacterium pinnipedii.
Ihama et al18 recently investigated the utility of IHC stain-
ing with a species-speciﬁc IgG1 type mouse monoclonal anti-
body against the 38-kDa antigen of theM. tuberculosis complex
(Vector Laboratories) to diagnose intestinal TB in archived
FFPE intestinal tissue sections of suspected intestinal TB pa-
tients. Goel and Budhwar19 also performed IHC localization of
M. tuberculosis complex antigen and compared it with Ziehl–
Neelsen staining in tissue granulomas of extrapulmonary TB.
They found positivity in only 36.1% of tuberculous granulomas
with Ziehl–Neelsen staining, whereas IHC staining was positive
in 100% of tuberculous granulomata with zero false positivity
and negativity. It is also our experience that this antibody is very
helpful and more sensitive than acid-fast bacterial stains identi-
fying M. tuberculosis in cutaneous TB lesions with few myco-
bacteria ( F4Fig. 4), but its speciﬁcity is not absolute because it also
stains other mycobacteria, both tuberculous and nontuberculous.
Mycobacterium leprae
The presence of mycobacterial antigens in leprosy skin
lesions has been studied by immunohistological methods using
monoclonal antibodies to Mycobacterium leprae–speciﬁc phe-
nolic glycolipid I (PGL-I) and to cross-reactive mycobacterial
antigens of 36 kDa, 65 kDa, and lipoarabinomannan (LAM).20
The staining patterns with monoclonal antibodies to 36 and 65
kd were heterogeneous and were also seen in the lesions of
other skin diseases. However, the in situ staining of mycobac-
terial cell wall–associated antigens (PGL-I and LAM) was seen
only in leprosy. Both antigens were abundantly present intra-
cellularly in CD68+ macrophages in the lesions of untreated
multibacillary patients, whereas only PGL-I was occasionally
seen in scattered macrophages in untreated paucibacillary le-
sions. These CD68+ macrophages containing mycobacterial
antigens were frequently located adjacent to T cells and as
scattered cells surrounding the granuloma. During treatment,
clearance of PGL-I from granulomas in multibacillary lesions
FIGURE 4. Histopathologic and
immunohistochemical findings in
a case of scrofuloderma. A, Scanning
power showed an ulcerated lesion
and dense nodular infiltrates in the
dermis. B, Higher magnification
demonstrated that the infiltrate was
composed of histiocytes, some mul-
tinucleated giant cells, neutrophils
and plasma cells. C, The same case
immunohistochemically studied with
anti-Mycobacterium tuberculosis anti-
body. D, At higher magnification,
several positive mycobacteria might
be found within the cytoplasm of the
histiocytes.
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occurred before that of LAM, although the former persisted in
scattered macrophages in some treated patients. The authors
observed a differential expression pattern of PGL-I and LAM
in the lesions of multibacillary patients with reactions during
the course of the disease as compared with those without re-
actions and suggest that the in situ expression pattern of PGL-I
and LAM in multibacillary patients may assist in early diag-
nosis of reactions versus relapse. As it has been stated above,
M. tuberculosis antibody strongly stains M. leprae (F5 Fig. 5).
Atypical (Nontuberculous) Mycobacteria
The atypical nontuberculous mycobacteria comprise
a heterogeneous group of acid-fast bacteria, which differ
from M. tuberculosis in their clinical manifestations, culture
requirements, and sensitivity to anti-mycobacterial drugs.
Cutaneous infections by nontuberculous mycobacteria
include speciﬁc entities, such as Buruli ulcer and swimming
pool granuloma, and other miscellaneous group of infec-
tions caused by Mycobacterium fortuitum, Mycobacterium
chelonae-abscessus, Mycobacterium kansasii, Mycobacte-
rium haemophilum, Mycobacterium scrofulaceum, Myco-
bacterium szulgai, Mycobacterium xenopi, Mycobacterium
neoaurum, Mycobacterium gordonae, and Mycobacterium
avium-intracellulare complex.
Buruli ulcer is a chronic cutaneous and soft tissue infection
by Mycobacterium ulcerans, which originates as a deep, pain-
less, usually solitary ulcer with undermined edge, involving
mostly distal areas of lower extremities of children and young
adults in endemic areas of Central andWest Africa, New Guinea,
Australia, southeast Asia, and Mexico. Histopathology shows
extensive coagulopathy necrosis involving the full thickness of
the dermis and subcutis. Usually, there are numerous clumps of
acid-fast bacilli in extracellular location. Although there is no
commercially available speciﬁc antibody against M. ulcerans,
Mwanatambwe et al21 detected immunoreactivity for synthetic
sugars of the terminal trisaccharide of M. leprae PGL-1M using
mouse monoclonal antibodies in tissues infected with M. ulcer-
ans. In our experience, M. ulcerans also express immunoreac-
tivity with anti-BCG and anti-M. tuberculosis antibodies.
Swimming pool granuloma consists of a solitary verru-
cous nodule or plaque involving mostly dorsum of the hands or
the forearms after superﬁcial trauma in an aquatic environment
caused byMycobacterium marinum. Histopathologically, early
lesions show suppurative granuloma, whereas more chronic
lesions exhibit poorly formed noncaseating granulomas with
variable epidermal changes. Acid-fast bacilli are found in
a minority of cases, but their isolation is readily achieved by
culture. Byrd et al22 demonstrated immunohistochemical posi-
tivity for mycobacteria with anti-BCG antibody in cutaneous
sporotrichoid lesions with positive culture for M. marinum.
Other nontuberculous mycobacteria produce a wide
range of cutaneous lesions. The M. fortuitum and M. chelonae/
abscessus group account for the majority of skin infections,
including solitary verrucous nodules, ulcers, furuncles,
abscesses, suppurative pannniculitis ( F6Fig. 6) and spindle cell
tumors. Mycobacterium fortuitum infections occur most
commonly in healthy individuals, whereas infections by
M. chelonae/abscessus group mostly develop in immunocom-
promised hosts. Several cases of disseminated infections caused
by M. avium-intracellulare complex have been reported in
AIDS patients. Cutaneous lesions in these patients are thought
to be a manifestation of partial immune restoration after initia-
tion of highly active antiretroviral therapy. Histopathology may
show suppurative granuloma in rare cases, but more often cuta-
neous lesions exhibit a granulomatous inﬁltrate composed of
voluminous histiocytes with granular cytoplasm, mimicking
FIGURE 5. Histopathologic and
immunohistochemical findings in
a case of lepromatous leprosy. A,
Dense diffuse infiltrate involving the
dermis. B, Higher magnification
demonstrated nodular aggregates of
foamy histiocytes in the infiltrate. C,
The same case stained with Myco-
bacterium tuberculosis antibody. D,
Mycobacterium leprae showed strong
cross reactivity withAU10 .
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histoid leprosy or a spindle or granular cell tumor. In our expe-
rience, M. avium-intracelluare shows strong immunoreactivity
with anti-BCG and anti-M. tuberculosis antibodies (F7 Fig. 7).
SPIROCHETAL INFECTIONS
The order Spirochaetales has 2 genera of medical
importance, Treponema and Borrelia.
Treponema pallidum
The treponematoses (syphilis, bejel, yaws, and pinta)
are caused by infection with the spirochete Treponema pallidum
and its various subspecies (Treponema endemicum, Treponema
pertenue, Treponema carateum). The treponemes responsible
for these different diseases are currently indistinguishable on
morphologic and routine serological grounds and cannot be
cultivated or maintained on artiﬁcial media.23
Treponema pallidum in FFPE tissue sections has classi-
cally been identiﬁed using silver impregnation staining techni-
ques, such as the Levaditi or Warthin–Starry (WS) stains,24 but
immunoperoxidase techniques using polyclonal antibodies
against T. pallidum improve spirochete visualization in FFPE
preparations and have been proposed as a sensitive and useful
method to avoid background staining and facilitate the identi-
ﬁcation and visualization of spirochetes in FFPE tissues.25,26
Phelps et al26 reported that immunoperoxidase for treponemes
was more sensitive than conventional silver stain or serology.
In 2009, we participated in a study evaluating T. pallidum
distribution patterns in mucocutaneous lesions of primary and
secondary syphilis by IHC.27 For this purpose, 34 biopsy
specimens of patients with primary and secondary syphilis were
stained with a speciﬁc polyclonal antibody against T. pallidum
(Biocare Medical). IHC detected spirochetes in 80% of the biop-
sies and no background staining was observed. This study iden-
tiﬁed different patterns of T. pallidum distribution: (1) In primary
syphilis, spirochetes were mainly distributed in the dermis or
lamina propria and were arranged in a perivascular pattern sur-
rounding and highlighting the vascular walls, adopting a peculiar
pattern of distribution that was deﬁned as a “vasculotropic pat-
tern.” Also, abundant T. pallidum with an intercellular distribu-
tion were noted within the lower layers of the epithelium
adjacent to the ulceration that was deﬁned as a “mixed
vasculotropic-epitheliotropic pattern.” (2) In secondary syphilis,
spirochetes were mainly located within the lower layers of the
epidermis, with an intercellular distribution that delineated the
keratinocyte walls and was deﬁned as an “epitheliotropic pat-
tern” ( F8Fig. 8). Scattered treponemes were also noted in more
superﬁcial epidermal layers and the papillary dermis. In 5 biopsy
specimens, abundant T. pallidum spirochetes were distributed
within the follicular infundibular epithelium and upper sweat
gland duct epithelial cells.
In all biopsy specimens corresponding to primary syphilis,
a consistently high density of treponemes was demonstrated,
whereas a variable density of treponemes was found in those
corresponding to secondary syphilis. In secondary syphilis, no
relationship could be demonstrated between spirochete density
and the evolution of the disease or the serological titers.
Finally, immunostaining with this anti-T. pallidum anti-
body should be interpreted with caution because it also stains
FIGURE 6. Histopathologic and
immunohistochemical findings in
a case of infective panniculitis caused
by Mycobacterium chelonae. A,
Scanning power showed a mostly
lobular panniculitis. B, Higher mag-
nification demonstrated suppurative
granulomas with bluish material at
the center, which corresponded to
clusters of mycobacteria. C, The
same case immunohistochemically
studied with Mycobacterium tuber-
culosis antibody. D, At higher mag-
nification numerous positive
mycobacteria were found using
M. tuberculosis antibody.
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some acid–alcohol–resistant bacilli and Helicobacter pylori,28
as well as some contaminant Treponema-positive bacteria that
are present in the tap water used to wash the histologic slides.
This latter event may be a pitfall especially in cutaneous
biopsies with an inﬁltrate rich in plasma cells.29
Borrelia burgdorferi
The borrelioses are arthropod-borne infections, usually
involving ticks of the genus Ixodes. Three genospecies of
Borrelia burgdorferi have been identiﬁed as human patho-
gens (Borrelia sensu stricto, Borrelia garinii, and Borrelia
FIGURE 7. Histopathologic and
immunohistochemical findings in
a cutaneous lesion by Mycocbacte-
rium avium-intracellulare in an AIDS
patient. A, Scanning power showed
discrete nodules of infiltrate in the
dermis. B, At higher magnification,
the nodules composed of ag-
gregates of histiocytes with foamy or
granular cytoplasm. C, The same
case immunohistochemically stained
with M. tuberculosis antibody. D,
Higher magnification showing
intense immunoreactivity for M.
tuberculosis antibody within the
cytoplasm of the histiocytes.
FIGURE 8. Histopathologic and
immunohistochemical findings in
a cutaneous lesion of secondary
syphilis. A, Scanning power showed
a lichenoid infiltrate. B, Higher
magnification demonstrated that
the infiltrate was mostly composed
of lymphocytes and plasma cells. C,
The same case immunohistochemi-
cally studied with a polyclonal anti-
body against Treponema pallidum. D,
At higher magnification, numerous
spirochetes were seen among the
keratinocytes of the lower layers of
the epidermis.
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afzelii), which are involved in erythema migrans, acroderma-
titis chronica atrophicans, Borrelia-associated lymphocytoma
cutis, and Borrelia-associated B-cell lymphoma. Borrelia has
also been suggested as a causative agent in a series of disparate
disorders, including progressive facial hemiatrophy (Parry–
Romberg disease),30 eosinophilic fasciitis,31 morphea, lichen
sclerosus et atrophicus, atrophoderma of Pasini and Pierini,32
and necrobiotic xanthogranuloma.33,34
Molecular detection of Borrelia in the skin has turned
out to be difﬁcult, and the results of direct detection of
Borrelia by histochemical and IHC methods and culture are
frequently negative. Studies by Aberer et al35 and Neubert et al36
conﬁrmed that detection of Borrelia in tissue is usually a difﬁ-
cult, time-consuming, and often frustrating task. This is mainly
due to the scant number of these spirochetes in many infections,
their tiny structure (0.2 mm thickness), their intimate relationship
to collagen bundles (which are 1–2 mm thick), and their variable
appearance according to the relation to the section plane.
Focus ﬂoating microscopy has recently been proposed as
the new “gold standard” for the diagnosis of cutaneous borre-
liosis.37 This new IHC method involves staining sections with
a B. burgdorferi antibody and then simultaneously scanning
sections through 2 planes: horizontally in serpentines, as in
routine cytology, and vertically by focusing through the thick-
ness of the section (usually 3–4 mm), using standard histological
equipment. The authors performed IHC staining in skin biopsies
of cutaneous borreliosis with a polyclonal rabbit antibody (Acris
BP1002, derived from immunization with whole-cell B. burg-
dorferi preparations strain B31, American Type Culture Collec-
tion No. 35210, reacting with 83- and 41-kDa ﬂagellin, 32-kd
OspB, and 31-kd OspA antigens and their fragments in Western
blots, with cross-reaction to T. pallidum, Borrelia hermsii, and
Borrelia parkeri). They found focus ﬂoating microscopy to be
more sensitive than PCR (96.0% vs. 45.2%) and nearly equally
speciﬁc. Spirochetes were observed surrounding the inﬂamma-
tory process and were mostly single, occasionally paired, and
delicate and, according to the section plane, very long and
undulated, or comma-like to dot, and there was no milky cloud
or veil. Within the inﬂammatory center, degenerative products
of Borrelia such as swollen, granular, or clumped material could
be found. Spirochetes or their degenerative products were fre-
quently located along or between collagen bundles, partially or
completely hidden if not visualized in the correct section plane.
Occasionally, Borrelia were also seen within vessels, yet never
in the epithelium of epidermis or adnexal structures.
CHLAMYDIAL INFECTIONS
Chlamydiae are obligate intracellular organisms that
share many features with bacteria, including a discrete cell
wall. There are 2 morphologically distinct species, Chlamydia
trachomatis and Chlamydia psittaci.
Chlamydia trachomatis
Different serotypes of C. trachomatis are responsible
for trachoma, urethritis, and lymphogranuloma venereum
(LGV). Since 2003, there has been a considerable rise in
the incidence of LGV in Western countries, almost exclu-
sively in men who have sex with men. Proctitis has been
by far the most common clinical manifestation of this infec-
tion in this scenario.38,39
Kumar et al40 studied the sensitivity and reliability of
immunodiagnostic assay for direct detection of C. trachomatis
infections in endocervical specimens from female patients. For
this purpose they developed species-speciﬁc monoclonal anti-
bodies that recognized the major outer membrane protein of all
serovars of C. trachomatis. They compared the reactivity of the
developed species-speciﬁc monoclonal antibody with the com-
mercially available direct ﬂuorescent antibody test and found that
the developed antibody had a higher sensitivity (97.22%) com-
pared with direct ﬂuorescent antibody for detection of chlamydial
infection in endocervical samples and can be used as a reliable
method in laboratories for the diagnosis of chlamydial infections.
We have recently studied 2 cases of LGV in men who
have sex with men who presented with bubonulus involving
the foreskin. IHC study using a monoclonal antibody reactive
against C. trachomatis D/K and L2 serovars (Acris Antibod-
ies catalog number AM00660PU-N) demonstrated the pres-
ence of the microorganisms within the cytoplasm of some
histiocytes of the granulomatous areas of lesional skin
( F9Fig. 9). In both cases, C. trachomatis particles were also
detected by PCR on tissue. Serovar L2b was identiﬁed by
PCR–restriction fragment length polymorphism genotyping.
Chlamydia psittaci
Psittacosis, caused by C. psittaci, usually presents as
a pneumonic illness with various constitutional symptoms.
Some patients develop a morbilliform rash or lesions resem-
bling the rose spots of typhoid fever. Erythema nodosum,41
erythema multiforme, erythema marginatum,42 and dissemi-
nated intravascular coagulation43 with cutaneous manifesta-
tions have also been reported. The ﬁndings are not speciﬁc for
psittacosis, either clinically or histopathologically.
In 2011, Aigelsreiter et al44 studied the association of
C. psittaci, Chlamydia pneumoniae, and C. trachomatis with
extranodal marginal zone lymphomas of mucosa-associated
lymphoid tissue (MALT). A total of 47 MALT lymphomas from
nongastrointestinal sites, including the skin, were studied by
both PCR and IHC for C. psittaci. IHC analysis for C. psittaci
was performed on FFPE sections using a Chlamydiaceae
family–speciﬁc mouse monoclonal antibody (Ab) directed
against chlamydial lipopolysaccharide (clone ACI-P; Progen).
Chlamydia psittaciwas detected at variable frequencies in MALT
lymphomas of different sites: 100% of lung lymphomas, 30% of
thyroid gland lymphomas, 13% of salivary gland lymphomas,
15% of ocular adnexal lymphomas, and 25% of skin lymphomas.
Together, nongastrointestinal MALT lymphomas were more fre-
quently infected by C. psittaci than their respective nonmalignant
control specimens. Positive reaction was exclusively found in
macrophages, which have been shown by multiple detection
methods to harbor viable and infectious C. psittaci.45
BARTONELLA
The genus Bartonella includes 19 distinct species, of
which at least 6 are responsible for human disease (Bartonella
henselae, Borrelia bacilliformis, Bartonella quintana, Borre-
lia elizabethae, Borrelia vinsonii, Borrelia koehlerae). These
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species are small, difﬁcult to culture, intracellular gram-negative
bacilli that are most easily visualized in tissue sections by using
a WS silver impregnation stain or a Brown–Hopps tissue Gram
stain.46 Bartonella henselae has been established as the pre-
dominant pathogen in cat scratch disease, although Borrelia
clarridgeiae has also been isolated from several cases.47 Bacil-
lary angiomatosis is caused by B. henselae and B. quintana,48
and B. quintana is also the agent of trench fever.49 Another
strain of Bartonella, B. bacilliformis causes verruga peruana.50
Bartonella henselae
IHC demonstration of B. henselae in the diagnosis of cat
scratch disease or bacillary angiomatosis had been reported by
Min et al51 and by Reed et al,52 but the “home-made” polyclonal
rabbit antiserum they used in their studies is not commercially
available. In 2006, Cheuk et al53 tested the utility of a commer-
cially available monoclonal antibody against B. henselae in 6
cases of cat scratch disease, 3 cases of bacillary angiomatosis,
and 24 cases of lymphadenopathy with reactive follicular and
monocytoid B-cell hyperplasia. They performed immunostaining
using the mouse monoclonal antibody clone H2A10 (Biocare
Medical; 1:100 dilution) and found lack of staining in other
tissue sections harboring bacillary and coccal bacteria, H. pylori,
M. tuberculosis,M. leprae, Cryptococcus, Aspergillus, and intes-
tinal spirochetosis conﬁrming that there was no cross-reactivity
against these microorganisms. In cat scratch disease, they found
clumps of organisms within the necrotic foci, along proliferating
vessels, and rarely within macrophages or monocytoid B cells. In
bacillary angiomatosis, clusters of the microorganisms are seen
with a granular appearance within the endothelial cells and extra-
cellularly in the stroma of the capillary proliferation (F10 Fig. 10).
The bacteria are easy to identify because of the strong color
contrast with the background. In comparison with WS stain,
immunostaining revealed more bacteria, and interpretation was
easier, especially where bacteria were present in low numbers.
Therefore, B. henselae antibody may be very helpful to
identify B. henselae in lesions of bacillary angiomatosis and
can aid in the distinction of cat scratch disease from other
causes of suppurative granulomatous lymphadenitis such as
tularemia, mycobacterial infection, brucellosis, fungal infec-
tion, and LGV. Immunostaining can also aid in the diagnosis
of early lesions or atypical manifestations of cat scratch dis-
ease in the heart, bone, lung, solitary breast tumor, liver,
spleen, and central nervous system. One potential pitfall,
however, is that negative result is possible in the exceptional
cases of cat scratch disease caused by B. quintana or
B. clarridgeiae.47 However, currently there also are commer-
cially available antibodies against B. quintana (Table 1) and
therefore distinction between B. henselae and B. quintana
may be immunohistochemically performed in lesional tissue.
RICKETTSIAL INFECTIONS
Rickettsia are small obligate intracellular bacteria that are
transmitted in most instances by the bite of an arthropod. The
various species of Rickettsia are endemic in different geograph-
ical locations, and this has inﬂuenced the naming of some of
the infections.54,55 Cutaneous lesions are present in most rick-
ettsial infections, with the exception of Q fever. T2Table 2 lists
the etiology of the various rickettsial infections of humans.
Rickettsia rickettsii
The dermatologic diagnosis of Rocky Mountain spotted
fever (RMSF) is often presumptive; the clinical presentation
FIGURE 9. Histopathologic and
immunohistochemical findings in
a biopsy of LGV. A, Scanning power
showed dense inflammatory infil-
trate involving diffusely the dermis.
B, At higher magnification, the infil-
trate mostly composed of lympho-
cytes, plasma cells, histiocytes, and
neutrophils. C, The same case im-
munohistochemically studied with
a monoclonal antibody directed
against chlamydial lipopolysaccha-
ride. D, Higher magnification dem-
onstrated Chlamydia trachomatis
particles within the cytoplasm of
some histiocytes of the infiltrate.
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includes skin rash and febrile illness with or without a clear
history of tick bite. The cutaneous histopathology of RMSF is
caused by endothelial damage by the rickettsial organisms
that produce a septic vasculitis.
Demonstrating rickettsiae in patient tissues using conven-
tional histochemical methods (Giemsa, Macchiavellos, and
Pinkerton stains) is difﬁcult to interpret and may produce
misleading results.56 Immunohistopathologic staining techniques
for detecting Rickettsia rickettsii revolutionized the detection of
these organisms in patient tissues and have been used since 1976.
Studies have emphasized the clinical utility of immunostaining
of skin biopsy specimens to guide patient care in suspected cases
of RMSF or as a method to investigate the pathophysiology of
RMSF by evaluating the anatomic distribution of rickettsial anti-
gens in speciﬁc organs, including the skin.57,58
Several authors59,60 have reported IHC detection of
R. rickettsii with different, noncommercially available,
polyclonal rabbit anti-R. rickettsii antibodies. Most reports
describe fatal, serologically unconﬁrmed RMSF for whom
a diagnosis of RMSF was established by IHC staining of
tissues obtained at autopsy. Rickettsial antigens reactive
with the anti-R. rickettsii antibody were visualized in mul-
tiple tissues from each patient including the skin. Rickett-
siae were identiﬁed in or around small vessels in skin
sections; however, the organisms were often sparse and
distributed sporadically in the tissue. Rickettsial antigens
and discrete coccobacilli were primarily located within the
cytoplasm and occasionally in nuclei of infected endothe-
lial cells; less frequently, they were located within macro-
phages and monocytes. Antimicrobial therapy may
diminish the detection of rickettsiae by IHC staining, and
scarcity of rickettsiae has been observed in skin biopsy
specimens after 24–48 hours of tetracycline or chloram-
phenicol therapy.61
Rickettsia akari
Rickettsialpox is a mild illness characterized by the
appearance of a primary eschar at the site of a mite bite
followed by fever, headache, and a papulovesicular rash.
Rickettsia akari, the etiologic agent, belongs to the spotted
fever group of rickettsial illnesses.
In the past, the laboratory diagnosis of rickettsialpox was
based on testing of paired serum samples to detect a 4-fold
increase in antibodies reactive with R. akari, a process requir-
ing several weeks. More recently, direct immunoﬂuorescence
testing and IHC staining using an anti-R. rickettsii antibody
have been used successfully to diagnose rickettsialpox using
FFPE skin samples60,62 due to cross-reactivity between R. rick-
ettsii and R. akari because they both belong to the spotted fever
group of rickettsia.63,64
FIGURE 10. Histopathologic and
immunohistochemical findings in
a case of bacillary angiomatosis
caused by Bartonella henselae in
a patient with AIDS. A, Dilated vas-
cular structures in the superficial
dermis. B, In the deep dermis, the
lesions showed the appearance of
a vascular proliferation. C, The same
case immunohistochemically studied
with a monoclonal antibody against
B. henselae demonstrated clusters of
bacteria in the stroma close to the
dilated vessels. D, Other area of
positive clusters of B. henselae in the
perivascular stroma.
TABLE 2. Rickettsial Infections and Their Corresponding
EtiologyAU11
Rickettsial Infection Organism
Rocky Mountain spotted fever Rickettsia rickettsii
Rickettsialpox Rickettsia akari
Scrub typhus Orientia tsutsugamushi
Q fever Coxiella burnetii
Boutonneuse fever Rickettsia conorii
African tick bite fever Rickettsia africae
Siberian tick typhus Rickettsia sibirica
Queensland tick typhus Rickettsia australis
Epidemic typhus Rickettsia prowazakii
Murine typhus Rickettsia mooseri
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Orientia tsutsugamushi
Scrub typhus is an acute febrile disease characterized by
high fever, headache, and rash. These symptoms are caused by
the intracellular gram-negative bacteria Orientia tsutsugamushi.
It is a major febrile disease in Korea, Japan, China, Thailand, etc.
Kim et al65 studied the clinical usefulness of IHC stain-
ing on skin biopsy specimens for the diagnosis of scrub
typhus compared with indirect immunoﬂuorescent antibody
assay (IFA), the “gold standard” for the deﬁnitive diagnosis
of scrub typhus. For this purpose, they tested skin biopsy
specimens from 63 patients with scrub typhus with ICR
mouse polyclonal anti-O. tsutsugamushi antibody (dilution,
1:200) against the O. tsutsugamushi Boryong strain. They
found that IHC staining of skin biopsy specimens, particu-
larly that of eschars, is sensitive and speciﬁc and can be
reliable for conﬁrming the diagnosis of scrub typhus. They
described that positive staining for Orientia antigens was
most apparent within and associated with the vascular endo-
thelium of capillaries, arterioles, venules, and veins. They
observed intracytoplasmic positive staining of the lining epi-
thelia of the sweat ducts and glands in the mid and deep
dermis. Orientia antigens were primarily located within the
cytoplasm of the infected endothelial cells and the macro-
phages around the blood vessels. Aggregates of fragmented,
granular, or coalesced Orientia antigens were also demon-
strated in some interstitial areas and more frequently in the
areas of the more inﬂamed lesions. Finally, IHC positive
staining was much more apparent for eschar lesions than
for maculopapular lesions.
NEISSERIAL INFECTIONS
Primary infections of the skin by N. meningitidis and
Neisseria gonorrhoeae are rare because these organisms are
unable to penetrate intact epidermis. However, cutaneous
lesions do occur quite commonly in meningococcal and gon-
ococcal septicemia; they take the form of a septic vasculitis.
Neisseria meningitidis
Neisseria meningitidis is a strict human pathogen that is
responsible for 3 major clinical syndromes, including chronic
meningococcemia (the indolent form of the disease) and 2
life-threatening infections: cerebrospinal meningitis and pur-
pura fulminans. The latter is a septic shock with disseminated
intravascular coagulation and extensive dermal thrombosis
leading to skin necrosis.
IHC demonstration of N. meningitidis in skin biopsy speci-
mens of patients with purpura fulminans has been reported in the
literature using several noncommercially available anti-N. men-
ingitidis antibodies.66 These studies have demonstrated that
N. meningitidis targets human endothelial cells and that this
interaction triggers the vascular damages that characterize pur-
pura fulminans.67 By IHC, they found microcolonies of N. men-
ingitidis within leukocytes, small blood vessels, and the dermal
interstitium.68 The most frequent ﬁnding was extracellular bacte-
ria adhering to the intraluminal surface of endothelial cells of
capillaries and postcapillary venules of the skin and, in some
circumstances, completely occluding the vascular lumen. Finally,
they found no relationship between the severity of the clinical
disease (as measured by Glasgow Meningococcal Prognostic
Score) or the histological changes and the number of meningo-
cocci identiﬁed.
TROPHERYMA WHIPPLEI
Tropheryma whipplei is an obligate intracellular bacte-
rium that causes Whipple disease (WD), which is a rare sys-
temic infection clinically characterized by diarrhea, fever,
weight loss, malabsorption, arthralgia, and, in some instances,
cardiac and central nervous system manifestations. Cutaneous
lesions in WD are infrequent, and the histological ﬁndings are
usually nonspeciﬁc.69 Speciﬁc cutaneous lesions have rarely
been described and usually involve the subcutaneous fat.70
The diagnosis of WD is usually based on the demonstra-
tion of PAS-positive, diastase-resistant bacilli in tissue sections,
but it may also be conﬁrmed by PCR or by demonstration
of characteristic bacillary bodies by electron microscopy.71
IHC analysis using antibodies speciﬁcally directed against
T. whipplei provides greater sensitivity and speciﬁcity than does
PAS staining and is used to detect the organism in various
tissues and bodily ﬂuids and on blood monocytes.72 Angelakis
et al73 tested 11 skin biopsies from patients with WD by PCR,
culture, and PAS and IHC staining. They used a rabbit polyclonal
antibody directed against T. whipplei that showed positive gran-
ular intracytoplasmic immunostaining within the macrophages in
the skin. They also found that T. whipplei DNA is frequent in the
skin biopsy of patients with classic WD without any apparent
skin lesions and that the bacteria were alive in the skin, thus
suggesting that the skin may be a reservoir for T. whipplei.
HELICOBACTER PYLORI
Helicobacter pylori is a gram-negative bacterium that is
considered a causative agent of peptic ulcer disease, gastric
lymphoma, and gastric carcinoma. An increasing number of
dermatologic diseases have been related to H. pylori infection
during the past decade, including rosacea, chronic idiopathic
urticaria, psoriasis, Behçet disease, nodular prurigo, lichen pla-
nus, and palmoplantar pustulosis.74 IHC demonstration of
H. pylori has been reported in the literature using several com-
mercially available anti-H. pylori antibodies in skin biopsy
specimens of patients with prurigo pigmentosa,75 squamous cell
carcinoma,76 oral lesions such as ulcerative/inﬂammatory les-
sions,77 and primary lymphoma.77 However, other studies have
failed to detect immunohistochemically the presence of H. pylori
in oral lichen planus.78 Irani et al77 tested 228 oral biopsies
diagnosed as ulcerative/inﬂammatory lesions, squamous cell car-
cinoma, and primary lymphoma with a rabbit polyclonal anti-H.
pylori antibody (Novocastra) and found that H. pylori positivity
was seen in both the coccoid and the spiral forms and mostly
detected in the epithelium (69.6%), followed by the lamina
propria (33.4%), blood vessels (4.2%), salivary gland ducts,
and the muscle layer of the tongue (0.3%). In addition, there
was a statistically signiﬁcant difference between the frequency
of H. pylori positivity in normal tissues and the lesions exam-
ined. In the prurigo pigmentosa case reported, H. pylori positiv-
ity was mainly found within the dilated hair follicles.73 Finally, it
has also been described that H. pylori transforms into uncultur-
able coccoid forms in unfavourable environments, resulting in
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the failure to detect this bacterium in oral samples by conven-
tional stains like Giemsa79 or culture techniques.80 IHC, how-
ever, will still detect coccoid/posttreatment forms of H. pylori.
FRANCISELLA TULARENSIS
The gram-negative coccobacillus F. tularensis is the
etiologic agent of tularemia, a disease that was classiﬁed in
2001 by the Centers for Disease Control into the most dan-
gerous pathogen group, category A, along with smallpox
and anthrax.81 Skin lesions in tularemia occur only in the
ulceroglandular form of the disease,82 which is characterized
by a papule at the site of the initial inoculation, followed
by an ascending lymphangitis. The occurrence of erythema
nodosum and erythema multiforme has been described.83
The primary lesion is an ulcer, with necrosis involving the
epidermis and upper dermis. The adjacent epidermis is usually
acanthotic with some spongiosis. The causative organism can-
not be seen in conventional histological preparations, but it can
be demonstrated in FFPE skin biopsies by direct immunoﬂuo-
rescence and IHC. Asano et al84 studied skin lesions of tulare-
mia using an anti-F. tularensis antibody (Dr. Hotta, NIID,
JapanAU7 ) and found positive immunostaining for F. tularensis
antigens mainly in abscesses and necrotic areas.
In summary, this article reviews the available immu-
nohistochemical markers that are helpful to identify bacterial
pathogens in cutaneous biopsies.
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CME EXAMINATION
1. The antibody against Treponema pallidum shows cross reactivity with:
a. Staphylococcus aureus
b. Helicobacter pylori
c. Pseudomona aeruginosa
d. Bartonella henselae
e. Streptococcus pyogenes
2. The strongest immunohistochemical staining of Treponema pallidum in secondary syphilis is seen:
a. Around the vascular walls of the papillary dermis
b. Around the vascular walls of the reticular dermis
c. Between the adipocytes
d. Around the eccrine glands
e. In the lower layers of the epidermis
3. Focus ﬂoating microscopy (FFM) has recently been proposed as the new “gold standard” for the diagnosis of:
a. Tuberculosis
b. Whipple disease
c. Cutaneous borreliosis
d. Cutaneous tularemia
e. Purpura fulminans
4. Which of the following bacteria are the etiologic agents of bacillary angiomatosis?
a. B. henselae and B. quintana
b. B. bacilliformis and B. quintana
c. B. elizabethae and B. vinsonii
d. B. koehlerae and B. henselae
e. B. henselae and B. vinsonii
5. Immunohistochemical demonstration of Neisseria meningitidis in skin biopsy specimens of patients with purpura fulminans
has demonstrated that N. meningitidis mainly targets:
a. Neutrophils
b. Histiocytes
c. Endothelial cells
d. Lymphocytes
e. Adipocytes
6. Which of the following bacteria have been used in bioterrorism?
a. Bacillus anthracis
b. Chlamydia trachomatis
c. Helicobacter pylori
d. Francisella tularensis
e. a and d
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Conclusions  
  
  
 1. A total of 25 different specific commercially available antibodies were 
identified and tested in cutaneous biopsy specimens from patients with a wide range 
of cutaneous viral and bacterial infections.  
 2. IHC was especially useful in the identification of microorganisms that are (1) 
difficult to detect by routine or special stains, (2) stain poorly, (3) present in low 
numbers, (4) noncultivable, or (5) exhibit an atypical morphology. 
 3. In early infections by HSV-1 and HSV-2, the strongest immunohistochemical 
expression of HSV is observed within the epidermal keratinocytes, while in early 
infections caused by VZV, the strongest immunohistochemical staining is seen in the 
cells of the outer root sheath of the hair follicle and in sebocytes of the sebaceous 
gland. 
 4. identifying Epstein-Barr–encoded RNAs (EBERs) by ISH has a higher sensitivity 
and specificity than immunohistochemical detection using commercialized antibodies 
against EBV latent membrane protein (LMP)-1. 
 5. Immunohistochemical staining with anti-CMV monoclonal antibody gives a 
nuclear staining pattern within the endothelial cells of the dermis in early-stage 
infections, and a nuclear and cytoplasmic pattern in late-stage infections. 
 6. The immunohistochemical detection of HHV-8 in the nuclei of proliferating 
cells in KS lesions can be demonstrated in all its epidemiologic variants and from the 
earliest phases of the process. 
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 7. Immunohistochemical detection of the HPV L1 capsid antigen is indicative of 
replicative HPV infections, but this method does not facilitate identification of the virus 
type involved,  thus indicating that IHC is only of limited value in the management of 
HPV infections. 
 8. Immunohistochemical detection of PVB19 in the cytoplasm of endothelial 
cells of congested capillaries of the papillary dermis in skin lesions of PPGSS and 
infectious erythema is pathogenically significant when the biopsy specimens are 
performed in the clinical setting of PPGSS and other related exanthems. 
 9. Immunoexpression of the monoclonal antibody SV-40 in lesional skin of 
patients with TS demonstrates positive staining of the large eosinophilic cellular 
inclusions within keratinocytes composing the inner root sheath of hair follicles. 
 10. In patients with measles, immunoexpression of the monoclonal antibody is 
found in the nuclei of epidermal keratinocytes, keratinocytes of the hair follicle, and 
lymphocytes of the dermal infiltrate. 
 11. Immunoexpression for VP1 peptide of the enterovirus group is seen in 
epidermal keratinocytes and acrosyringeal keratinocytes of patients with HFMD.  
 12. Immunoexpression for HTLV-1 is seen as a dot-like paranuclear positivity, 
probably located in Golgi apparatus of neoplastic lymphocytes, in patients with ATTL.  
 13. Due to overpurification by the manufacturer in recent years, B124 antibody 
can no longer be used for screening of bacterial and fungal infections, as originally 
proposed, and the current potential use of the commercially available anti-BCG 
antibody should be restricted to the search of mycobacteria in FFPE samples.  
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 14. Due to cross-reactions, the anti-Mycobacterium tuberculosis antibody can 
be used in the immunohistochemical diagnosis of cutaneous tuberculosis, leprosy and 
several cutaneous infections due to atypical mycobacteria.  
 15. IHC demonstrates different patterns of T. pallidum distribution in the skin 
depending on the stage of the infection: a “vasculotropic pattern” and “mixed 
vasculotropic-epitheliotropic pattern in observed in primary syphilis, while an  
“epitheliotropic pattern” in secondary syphilis. 
 16. We could immunohistochemically demonstrate the presence of C. 
trachomatis within the cytoplasm of histiocytes in the granulomatous areas of lesional 
skin in patients with LGV. These detection was performed using a monoclonal antibody 
reactive against D/K and L2 serovars of the bacteria. These findings have not been 
previously reported in the literature.  
 16. There are commercially available antibodies against B. henselae and B. 
quintana and, therefore, distinction between the two can be immunohistochemically 
performed in lesional tissue. 
 17. Different reports have demonstrated immunohistochemical detection of 
microcolonies of N. meningitidis within leukocytes, small blood vessels, and the dermal 
interstitium in skin biopsy specimens of patients with purpura fulminans. These 
authors used different non-commercially available monoclonal antibodies against N. 
meningitidis, however we failed to reproduce their findings using the monoclonal 
antibody that is commercially available.  
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Conclusiones  
  
 1. Un total de 25 anticuerpos disponibles comercialmente fueron identificados 
y aplicados a muestras de piel provenientes de pacientes con un amplio abanico de 
enfermedades infecciosas por virus y bacterias.  
 2. La IHQ resultó ser especialmente útil en la identificación de microorganismos 
que: (1) son difíciles de detectar con las tinciones de rutina o especiales, (2) se tiñen 
con dificultad, (3) están presentes en bajo número en la piel, (4) no son cultivables o 
crecen con dificultad en los cultivos, y (5) presentan una morfología atípica. 
 3. En las infecciones tempranas por virus herpes simple (VHS)-1 y 2 la 
intensidad de la tinción IHQ es mayor en los queratinocitos de la epidermis, mientras 
que en infecciones tempranas causadas por el virus varicela-zoster (VVZ) la mayor 
intensidad se observa en la vaina radicular externa del folículo piloso y los sebocitos de 
la glándula sebácea.  
 4. La identificación de ARNs codificados del virus de Epstein-Barr mediante 
hibridación in situ (HIS) tiene una mayor sensibilidad y especificidad que la detección 
IHQ del virus usando anticuerpos disponibles comercialmente frente a la proteína 
latente de mebrana-1 del virus.  
 5. El patrón de tinción IHQ del citomegalovirus en la piel es principalmente 
nuclear en las fases tempranas de la infección, y citoplasmático en fases más 
avanzadas.  
 6. La presencia de material genómico del HHV-8 en los núcleos de las células 
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proliferantes del sarcoma de Kaposi puede demostrarse mediante IHQ en todas sus 
variantes epidemiológicas y desde las fases más iniciales del proceso.  
 7. La detección IHQ del antígeno de cápside L1 del virus del papiloma humano 
(VPH) indica replicación activa del virus, pero no permite identificar el tipo de virus 
implicado en la infección cutánea, por lo que la utilidad de la IHQ en las infecciones por 
VPH es limitada.  
 8. La detección IHQ de PVB19 en el citoplasma de las células endoteliales de los 
capilares congestivos de la dermis papilar en muestras cutáneas de síndrome papular 
purpúrico en “guante y calcetín” (SPPGC)  y eritema infeccioso, tiene relevancia 
diagnóstica en biopsias cutáneas realizadas en el contexto clínico de SPPGC. 
 9. La detección IHQ del anticuerpo monoclonal SV-40 en biopsias cutáneas de 
pacientes con tricodisplasia espinulosa muestra positividad en las inclusiones 
nucleares eosinofílicas de los queratinocitos de la vaina radicular interna de los 
folículos pilosos. 
 10. La detección IHQ del virus del sarampión en la piel demuestra presencia 
viral en los núcleos de los queratinocitos epidérmicos y del folículo piloso, así como en 
los linfocitos del infiltrado inflamatorio dérmico. 
 11. La detección IHQ del péptido VP1 común al grupo de los enterovirus 
demuestra presencia viral en los núcleos de los queratinocitos epidérmicos y del 
acrosiringio en muestras de piel de pacientes con enfermedad boca-mano-pie. 
 12. La detección IHQ del virus HTLV-1 demuestra presencia viral en la región 
paranuclear (aparato de Golgi) de los linfocitos neoplásicos en pacientes con Leucemia 
/linfoma de células T del adulto.  
Ana M. Molina Ruiz 
Immunohistochemistry in the Diagnosis of 
Cutaneous Viral and Bacterial Infections 
 
 49 
 13. Debido a sucesivas purificaciones llevadas a cabo por el fabricante, el 
anticuerpo B124 no es útil en el diagnóstico de screening de infecciones víricas y 
bacterianas como se propuso originalmente, y su uso, hoy en día, se limita a la 
detección de infecciones por micobacterias.  
 14. Debido a reacciones cruzadas con otras bacterias, el anticuerpo anti-
Mycobacterium tuberculosis es útil en el diagnóstico de tuberculosis, lepra y algunas 
infecciones cutáneas por micobacterias atípicas.  
 15. La detección IHQ de T. pallidum en biopsias de piel de pacientes con sífilis 
pone de manifiesto diferentes patrones de distribución del microorganismo según el 
estadío de la infección, con un patrón "vasculotrópico" y mixto "vasculotrópico-
epidermotrópico" en sífilis primaria y un patrón "epidermotrópico" en sífilis 
secundaria.  
 16. La detección inmunohistoquímica de C. trachomatis con un anticuerpo 
monoclonal dirigido contra los serotipos D/K and L2 de la bacteria, demonstró la 
presencia de microorganismos en el citoplasma de los histiocitos en las áreas 
granulomatosas de pacientes con linfogranuloma venéreo. Estos hallazgos no han sido 
descritos previamente en la literatura.  
 16. Existen anticuerpos monoclonales específicos para la detección de B. 
henselae y B. quintana y, por tanto, la distinción entre ambas puede hacerse mediante 
IHQ en muestras de tejido fijado en parafina. 
 17. Diferentes autores han demostrado la presencia de microcolonias de N. 
meningitidis en los leucocitos, capilares y en el intersticio de la dermis en biopsias de 
pacientes con púrpura fulminans. Estos autores usaron anticuerpos monoclonales no 
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disponibles comercialmente, sin embargo, nosotros non hemos logrado confirmar 
estos hallazgos utilizando el anticuerpo monoclonal que está disponible 
comercialmente para la detección de N. meningitidis.  
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Conde-Taboada, A. Dermatologic Therapies. 2012: 283-362. Editorial Bentham 
Science Publishers Ltd. United Arab Emirates. 2012. ISBN: 978-1-60805-431-2. 
 
7. Molina Ruiz A, Requena L. Seudolinfomas cutáneos. En: Dermatología 
Práctica Ibero-Latino-Americana, 2ª Edición, Torres V, Camacho F, Mihm M, 
Gonzalez S, Jurado E, Sánchez Carpintero E, eds. México, Lito Laser SA de CV, 
2012: 137.1-123.12.  
 
8. Molina-Ruiz AM. Alopecia androgenética e hiperplasia benigna de próstata. 
En: Arias- Santiago S, Serrano S. Comorbilidades en Alopecia Androgenética. 
Glosa. (In press) 
 
9. Machan S, Molina-Ruiz AM, Requena L. Dermal Hypertrophies. En: Bolognia 
JL, Schaffer JV, Cerroni L. Dermatology, Fourth edition, London, Elsevier. (In 
press). 
 
10. Molina-Ruiz AM, Fuertes L, Carranza C, Requena L. Immunohistology and 
Molecular Studies of Sweat Gland Tumors. En: Plaza J. Applied 
Immunohistochemistry and Molecular Studies in the Evaluation of Skin 
Neoplasms. Springer Science + Business Media. (In press) 
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11. Molina-Ruiz AM, Requena L. Panniculitis. En: Jeffrey P. Callen, Joseph L. 
Jorizzo. Dermatological Signs of Systemic Disease. 5th Edition. Elsevier. (In 
press). 
 
 
Teaching activities/invited lectures 
 
1. "Sexually Transmitted Diseases". Center on International Cooperation, 
Médicos del Mundo Andalucía, Sevilla, Spain, 22 September 2007.  
 
2. “Residency training in Dermatology”. II National Congress of the Spanish 
Dermatology Residents, Madrid, 26-27 October 2007. 
 
3.  “Basic curriculum in Psychodermatology”. National Reunion of the Spanish 
Dermatology and Psychiatry Group". Zaragoza, Spain, 22-23 February 2008. 
 
4.  “Psychodermatology, a new subspecialty in Dermatology”. 36th National 
Congress of the Spanish Academy of Dermatology and Venereology. Barcelona, 
Spain, June 2008. 
 
5.  “Training perspectives and future proffesional activities of a Dermatology 
Resident”.  Residerm, Barcelona, Spain, January 2009. 
 
6.  “Management strategies of non-melanoma skin cancer in transplant 
patients”. 12th International Congress on skin cancer. Tel Aviv, Israel. 3-6 May, 
2009. 
 
7. "Introduction to Psoriasis". I National Course of Psoriasis for Dermatology 
Residents, Valencia, Spain, 22-23 May 2009.  
 
8. "Quality of life of patients with psoriasis". Update on Psoriasis Course, 
Barceloneta, Puerto Rico, 14-17 November 2009.  
 
9. "Cutaneous Exanthems". Emergency Dermatology Course. La Moraleja 
Hospital, Madrid, Spain, 18 December 2009.  
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10. "Effects of tumor necrosis factor blockade on cardiovascular risk factors in 
patients with psoriasis". 5th Annual Conference of Alexandria Society of 
Dermatology, Venereology and Andrology, Alexandria, Egypt, 18-20 February 
2010. 
 
11. "Management strategies for non-melanoma skin cancers in transplant 
patients". The Egyptian-Spanish Dermatology Conference. Alexandria, Egypt, 
18-20 February 2010. 
 
12. "Vasculitis". III Course of Emergency Dermatology. University Hospital Gregorio 
Marañón, Madrid, Spain, 19 November 2010. 
 
13. "Emergency scenarios in Dermatology". V National Congress of the Spanish 
Dermatology Residents. Málaga, Spain, 16-17 September 2011. 
 
14. "Actas Dermo-Sifiligráficas joins the world of social networking". 40th 
National Congress of the Spanish Academy of Dermatology and Venereology. 
Oviedo, Spain, 6-9 June 2012.  
 
15. "Immunohistochemistry of viral infections". XIX Congreso Ibero-
Latinoamericano de Dermatología (CILAD). Sevilla, Spain, 18-22 September 
2012. 
 
16. "Complex clinical cases in trichology". I Update on Trichology Course. 
University Hospital Ramón y Cajal, Madrid, Spain, 17 May 2013. 
 
17. "Androgenetic alopecia". Alopecias Update Course. Hotel Room Mate Oscar, 
Madrid, Spain, 22 May 2013.  
 
18. "Saved by the patient". 17th Joint Meeting of the International Society of 
Dermatopathology-American Society of Dermatopathology. Denver, USA. 19-20 
March 2014. 
 
19. "Research in Trichology". II Update on Trichology Course University Hospital 
Ramón y Cajal, Madrid, Spain, 28 March 2014. 
 
20. "Histopathology of Alopecias". Alopecias Update Course. Hotel Loft, Madrid, 
Spain. 8 May 2014.  
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21. "Immunohistochemistry in the diagnosis of cutaneous infections". Memorial 
Sloan Kettering Cancer Center, 28th July 2014. 
 
22. "Immunohistochemistry relevant to Dermatopathology". Memorial Sloan 
Kettering Cancer Center, 1st August 20014.  
 
Oral presentations  
 
76 Oral Communications in National and International Congresses 
 
Courses, congresses and reunions attended 
 
15 International Courses attended 
17 International Reunions and Congresses attended 
90 National Courses attended 
30 National Reunions and Congresses attended 
 
Extracurricular activities and other employment experience 
 
International Cooperation 
 
09/1994-10/1998: Coordination of the Red Cross “young volunteer” program, Zaragoza, 
Spain. 
 
06/2003-08/2003: Medical staff volunteer at Red Cross Inmigration Center, Tarifa, Cádiz, 
Spain. 
 
05/2006-05/2009: Médicos del Mundo. Homeless program, Sevilla, Spain. 
 
05/2007-05/2009: Médicos del Mundo. Coordination of the regional HIV program, Sevilla, 
Spain. 
 
08/2007-09/2007: Medical staff volunteer at Mother Theresa of Kolkata Center, Kolkata, 
India.  
 
07/2008-09/2008: Médicos del Mundo, Pharmacy system analysis program in the districts of 
Quissanga, Ibo, Mecufi and Metuge in the province of Cabo Delgado, Mozambique, Africa.  
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Camp America International Exchange Program.  
06/1999-09/1999: Medical Staff, Camp Skimino, Virginia. USA. 
06/2000-09/2000: Medical Staff, Camp Na-Sho-Pa, New York. USA.  
06/2001-09/2001: Medical Staff, Camp Valley-Forge, Philadelphia. USA.  
06/2002-09/2002: Medical Staff, Camp Blue-Ridge, Pennsylvania. USA.  
01/2000-05/2009: Interviewer at Camp America Recruitment Center, London, United 
Kingdom. 
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Prof. Heinz Kutzner
